Document:

Exhibit 10.11
AGREEMENT

AGREEMENT, dated as of November 6, 2003, by and between OPTIGENEX INC., a
Delaware corporation with offices at 750 Lexington Avenue, 20th Floor, New York,
NY 10022 ("Buyer"), on the one hand, and Mr. PIERRE APRAXINE of 59 West 12th
Street, Apt. 2C, New York, NY 10011 ("Apraxine"), Mr. Michael L. K. Hwang as
executor of the ESTATE OF JOHN B. ELLIOTT of 8 Blueberry Hill, Irvington, NY
10533 ("Elliott"), Mr. ANTHONY CHRISTIAN FLOOD of 21 Selwood Terrace, London SW
5, England, United Kingdom ("Flood") and Mr. PETER KOEPKE of 930 East Mountain
Road South, Cold Spring, NY 10516 ("Koepke") (Apraxine, Elliott, Flood and
Koepke referred to herein jointly and severally as the "Original Owners"), on
the other hand.

WHEREAS, the Pero Family Limited Partnership, a Vermont limited partnership
("Pero"), acquired sole ownership of CampaMed Corp., a Delaware corporation (the
"Original CampaMed"), as a result of its acquisition of certain shares of stock
of the Original CampaMed from the Original Owners pursuant to that stock
purchase agreement between Pero and the Original Owners dated as of December 12,
1996, as amended by that amendment dated as of November 19, 1997 (the "Original
Agreement");

WHEREAS, the Original Agreement provided for the Original Owners to receive a
deferred payment to be paid out on a contingent basis in the form of a royalty
on sales relating to the exploitation of certain assets then owned by the
Original CampaMed, as specified in Schedule "A" to the Original Agreement (the
"Original Assets"), including without limitation any compound, substance or
ingredient derived or isolated from Cat's Claw (a/k/a Uncario Tormentosa) (a
"Cat's Claw Substance"), such as that product presently known as C-Med 100;

WHEREAS, the Original Assets were subsequently transferred to CampaMed LLC, a
New Jersey limited liability company ("Seller"), and Seller assumed the
aforementioned royalty obligation;

WHEREAS, Buyer now wishes to purchase the Original Assets from Seller (the
"Transaction") pursuant to an Asset Purchase Agreement dated November 6, 2003 by
and among Seller, Buyer and certain other parties (the "Acquisition Agreement");
and

WHEREAS, as part of the Transaction, Buyer and Seller wish to discharge the
aforementioned royalty obligation, to receive the Original Owners' approval of
the Transaction, and to obtain certain consulting services from the Original
Owners with respect to the "Acquired Assets" (such term when used herein to have
the same definition as it has in the Acquisition Agreement, such that it
includes, inter alia, all of the Original Assets); and the Original Owners are
willing to relinquish said royalty right, to grant such approval and to provide
such services, upon the terms set forth below;

NOW, THEREFORE, in consideration of the mutual promises contained herein and for
other good and valuable consideration received, the parties hereby agree as
follows:

1. Representations, Warranties & Covenants. (a) In order to induce Buyer to
enter into the Acquisition Agreement and to consummate the Transaction and to be
bound by the terms and conditions hereof, each of the Original Owners
represents, warrants, covenants and confirms the following:

(i) Annexed as Exhibit I hereto is a true, complete and correct copy of the
Original Agreement, including all exhibits, schedules, amendments and
supplements thereto

(ii) The Original Owners consent to the execution and delivery of the
Acquisition Agreement and to the consummation of the Transaction.

(iii) All shares of capital stock of the Original CampaMed not then owned by
Pero were acquired by Pero from the Original Owners under the Original Agreement
and Pero, as a result thereof, became the sole stockholder of the Original
CampaMed.

(iv) To the knowledge of the Original Owners, there is no entity known as
CampaMed Inc. or CampaMed Corporation that has or ever had any claim to title of
the Original Assets, and all references to "CampaMed Inc." and/or "CampaMed
Corporation" in the Original Agreement and related documents and communications
are intended to and should be deemed references to the Original CampaMed.

(v) Effective upon the closing of the Transaction (the "Closing"), each of the
Original Owners, on behalf of themselves and their successors and assigns,
waives, releases and relinquishes, in favor of Buyer, any right, claim, interest
and lien which any such party or any affiliate thereof now has or hereafter may
have in and to any of the Acquired Assets, whether or not such Acquired Assets
were the subject of the Original Agreement; provided, however, the foregoing
shall not be deemed to affect the non-exclusive nature of the rights granted
with respect to the medical herbarium list constituting part of the Original
Assets.

(vi) Other than the Original Agreement and this agreement, none of the Original
Owners is party to any agreement (or amendments or supplements thereto) relating
to the Original Assets and/or the Acquired Assets and none of the Original
Owners has sold, transferred or assigned any of its rights relating to the
Original Agreement and the Original Assets.

(b) In order to induce Buyer to enter into the Acquisition Agreement and to
consummate the Transaction and to be bound by the terms and conditions hereof,
Michael L. K. Hwang, as executor of the Estate of John B. Elliott, represents
that said estate has not distributed and retains all of the rights held by John
B. Elliot relating to the Original Agreement and the Original Assets.

(c) In order to induce the Original Owners to enter into this agreement, to
approve the Transaction, and to grant the consents and releases set forth
herein, Buyer hereby represents, warrants and confirms to each of the Original
Owners that:

(i) Annexed as Exhibit II hereto is a true, complete and correct copy of the
Acquisition Agreement, including all exhibits, schedules, amendments and
supplements thereto.

(ii) No agreements, undertakings, or understandings exist between Buyer (or any
affiliate) and Seller (or any affiliate) with respect to the Transaction or the
Original Assets other than the Acquisition Agreement, and the Acquisition
Agreement sets forth the entirety of the agreement between them in this regard.

(iii) Buyer has the full power and authority to enter into and perform this
agreement, and this agreement will not conflict with any other agreement to
which Buyer is a party, or otherwise violate any right of any third party.

(d) With respect to any breach by any party of its or his representations,
warranties and covenants hereunder, the breaching party hereby indemnifies the
other parties against any loss or damage, including reasonable attorneys' fees,
incurred by reason of said breach.

2. Waivers & Releases. (a) Subject to and effective upon Full Compliance (as
defined below), each of the Original Owners waives all defaults (and all rights
and remedies with respect thereto), if any, which have arisen under the Original
Agreement, including without limitation all defaults, if any, under Section 4 of
the aforementioned amendment to the Original Agreement.

(b) At or before the Closing, outstanding royalties due under the Original
Agreement in the amount of $20,000 will be paid by Buyer to the Original Owners
(by delivering a set of certified checks made payable to the order of each
Original Owner for his respective percentage share thereof, as specified in
Schedule "B"); and releases (i) executed respectively by Pero, Seller and the
Original CampaMed in favor of the Original Owners in the form annexed hereto as
Exhibit III; (ii) executed by the Original Owners in favor of the CampaMed
Parties in the form annexed hereto as Exhibit IIIA; and (iii) executed by the
Original Owners in favor of Buyer in the form annexed hereto as Exhibit IIIB,
will be exchanged.

(c) Subject to and effective upon Full Compliance, the Original Agreement shall
be deemed null and void, and thereafter none of Buyer, any of the CampaMed
Parties or any of the Original Owners shall have any liability under the
Original Agreement.

(d) As used herein, "Full Compliance" shall mean that each and all of the
following conditions precedent have been met: (i) the Closing has been
completed; (ii) the $20,000 in royalties set forth in Section 2(b) payable in
full to the Original Owners shall have been delivered to Peter Koepke on behalf
of the original owners; and (iii) Peter Koepke, on behalf of the Original Owners
shall have received fully executed duplicates of the releases described in
clause (i) of Section 2(b) by Seller, Pero and the Original CampaMed.

3. Further Assurances. Each of the parties shall from time to time after the
Closing, at the sole cost and expense of the requesting party, take any and all
actions, and execute, acknowledge, deliver, file and/or record any and all
documents and instruments that any other party may reasonably request in order
to more fully effect, consummate, confirm or evidence the transactions
contemplated hereby or to more effectively transfer, convey and assign to Buyer
and/or a designee thereof, and put Buyer and/or a designee thereof, as the case
may be, in actual possession and control of, the Acquired Assets. Each of the
Original Owners further agrees to assist or consult with Buyer and/or a designee
thereof in good faith, as reasonably appropriate, if additional documents or
instruments are required for submission to the U.S. Patent and Trademark Office
or trademark offices worldwide to carry out the purpose and intent of this
agreement. Without limiting the generality of the foregoing, each of such
parties shall cooperate and take all steps reasonably requested by Buyer to
perfect, confirm and protect Buyer's rights, including without limitation,
intellectual property rights, title and interest in and to the Acquired Assets
including without limitation, executing and delivering all documents, filing
registration and assignment documents, and giving testimony, at Buyer's expense.

4. Consulting Services. (a) For the one-year period commencing on the date of
the Closing, the Original Owners agree to perform such consulting services as
Buyer may from time to time reasonably request, subject to their professional
availability and with Buyer to reimburse the reasonable expenses incurred by the
Original Owners in performing such requested consulting services, and provided
that such consulting services shall not require more than 20 hours of time in
the aggregate.

5. Sales Royalties. (a) Effective upon the Closing, Buyer will, subject to the
terms hereof, pay royalties to the Original Owners in connection with all sales
of any product or service based upon or derived from the Original Assets (a
"Product"), including without limitation the sale or licensing of any Cat's Claw
Substance, until such time as a total aggregate amount of $347,700 of such
royalty earnings (the "Total Royalty Amount") has been paid out to Original
Owners hereunder. Said royalties shall be as follows:

(i) When the Product consists of an article that is sold in the final form in
which it will be marketed to the public (whether sold at retail or wholesale)
("Product Sales"), an amount equal to 6% of the applicable Revenues (as defined
below).

(ii) When the Product consists of an ingredient or component sold to the trade
for incorporation into a third-party product to be produced and sold by an
unaffiliated third-party manufacturer ("Ingredient Sales"),10% of the applicable
Revenues.

(iii) If Buyer (or any affiliate) grants an unaffiliated third party a license
to manufacture or produce any Product ("Product Licensing"), an amount equal to
50% of the applicable Revenues.

(b) As used herein, "Revenues" shall mean the following: (i) in the case of
Product Sales or Ingredient Sales, as the case may be, the total gross amount of
revenues received by Buyer or any affiliate from Products Sales or Ingredient
Sales, as the case may be, net of refunds, rebates or returns, but without other
deductions of any kind; and (ii) in the case of Product Licensing, the total
gross amount of royalties, license fees, advances, guarantees, or other
compensation paid to Buyer or any affiliate by the licensee (or any affiliate of
the licensee) in consideration of each applicable license.

(c) Effective upon the Closing, in the event of a sale of a controlling interest
in Buyer, or a sale by Buyer of substantially all of the Original Assets, or a
sale by Buyer of substantially all rights in C-Med 100 or any other Cat's Claw
Substance, or if any shares of Buyer (or any affiliate having any right to
exploit the Original Assets) become publicly tradable on any exchange in the
United States, Canada or Europe (such as NASDAQ), Buyer shall immediately make
payment in full to the Original Owners of the full amount of the then unpaid
balance of the Total Royalty Amount, if any. In this regard, any license granted
with respect to the exploitation of the Original Assets, and/or of C-Med 100 or
any other Cat's Claw Substance, shall be deemed a sale if such license provides
the licensee with exclusive rights in the United States and has a term in excess
of five years.

(d) Buyer may at any time fully discharge its obligation to pay and account for
royalties hereunder by making payment in full of the then-outstanding balance of
the Total Royalty Amount.

6. Accounting. (a) Royalties shall be calculated and paid on a quarterly basis.
Buyer shall render a written royalty statement to each of the Original Owners
for each calendar quarter hereunder no later than 30 days after the close
thereof. Each such statement shall show the source and amount of Revenues
attributable to the applicable quarter, and the calculation of the royalty
earnings due thereon, and shall be accompanied by payment in full of the
Original Owner's share of such earnings. Upon request, Buyer shall provide such
additional detail as the Original Owners may reasonably require to enable them
to verify said calculation. Royalty statements and payments shall continue to be
rendered until such time as the Total Royalty Amount is paid in full.

(b) The Original Owners shall share in royalty earnings hereunder on the
proportional percentage basis specified in the attached Schedule "B," and each
payment of quarterly royalty earnings hereunder shall be made by making separate
payment to each Original Owner of his respective percentage share thereof, as
specified in Schedule "B," supported by a copy of the applicable royalty
statement. All payments shall be made in United States dollars by means of a
check drawn upon a U.S. bank. Any overdue amounts shall accrue interest at the
rate of 10% per annum, calculated from the original due date. Each payment shall
be accompanied by the applicable statement, as provided above.

(c) The Original Owners shall have the right to inspect and audit all of Buyer's
records and books of account insofar as they relate to this agreement. Such
audits shall take place upon reasonable notice, during normal business hours,
but not more than once in any calendar year. The cost of each such audit shall
be borne solely by the Original Owners unless accounting errors amounting to
seven and one-half percent (7.5%) or more of the applicable total are found to
the disadvantage of any Original Owner, in which case the cost of said
inspection and audit shall be borne by Buyer.

7. Stock Options. Effective upon the Closing, Buyer shall issue to each of the
Original Owners options (the "Options") to purchase an aggregate of 150,000
shares of the common stock of Buyer ("Common Stock") at an exercise price of one
tenth of one cent ($0.001) per share (i.e., a total aggregate price of $150 for
all such shares), such Options to be issued to each Original Owner in the amount
obtained by multiplying the percentage set forth across from each individual
owner in Schedule B by 150,000. The Options will be issued under, and subject
to, a stock option agreement substantially in the form of Exhibit IV ("Option
Agreement"); provided, however, that upon exercise of the Option the Common
Stock will be afforded, for a period ending on October 1, 2006, no less
favorable rights and treatment, and no more unfavorable obligations, in respect
of the sale and registration thereof than is afforded by Buyer to Richard S.
Serbin individually.

8. Miscellaneous. (a) For the purposes of this agreement, entities shall be
deemed to be affiliates of, or affiliated with, one another, if, directly or
indirectly, either controls the other or both are under common control. In this
regard, "control" shall deemed to be mean the power to direct the management and
policies of the controlled entity, whether through ownership of voting
securities, by contract or otherwise. Entities shall be deemed to be
unaffiliated only if no such control exists.

(b) This agreement constitutes the entire agreement, and supersedes all prior
agreements and understandings (oral or written), between the parties with
respect to the subject matter hereof.

(c) This agreement shall be governed by and controlled by and interpreted under
the internal laws of the State of New York, without regard to conflicts of law
principles. Each party hereto (i) agrees that any legal suit, action or
proceeding arising out of or relating to this agreement shall be instituted
exclusively in the New York State Supreme Court, County of New York or in the
United States District Court for the Southern District of New York, (ii) waives
any objection which such party may have now or hereafter based upon forum non
conveniens or to the venue of any such suit, action or proceeding, and (iii)
irrevocably consents to the jurisdiction of the New York State Supreme Court,
County of New York and the United States District Court for the Southern
District of New York in any such suit, action or proceeding. Each party further
agrees to accept and acknowledge service of any and all process which may be
served in any such suit, action or proceeding in the New York State Supreme
Court, County of New York or in the United States District Court for the
Southern District of New York and agrees that service of process served in
compliance with the notice provision of subsection (d) below will be deemed in
every respect effective service of process upon the recipient in any suit,
action or proceeding Notwithstanding the foregoing, any party may elect to have
any or all disputes arising hereunder adjudicated by binding arbitration in the
State and County of New York before a single arbitrator pursuant to the
international arbitration rules of the American Arbitration Association (the
"AAA"), other than claims for preliminary injunctive relief or other
pre-judgment remedies. If no single arbitrator can be agreed upon by the
parties, the arbitrator(s) shall be selected in accordance with the rules of the
AAA. The foregoing obligation to arbitrate shall be specifically enforceable.
The prevailing party (plaintiff or defendant) in any suit, action, proceeding or
arbitration hereunder shall be entitled to recover, in addition to any other
relief awarded, its reasonable attorneys' fees and other costs and expenses.

(d) All notices, statements and communications required or permitted to be given
hereunder shall be sent to the parties, at their respective addresses, as first
set forth above, by first-class mail, by facsimile transmission, or by an
established "overnight" courier service (such as FedEx); except for notices
relating to termination or to claimed breach, which shall be sent by certified
mail (return receipt requested) or by such courier service, with an advance copy
by facsimile transmission or e-mail. A copy of all notices to the Original
Owners shall be provided to the following attorneys:

Stout & Thomas                            Tel: (212) 754-6120
477 Madison Avenue, 15th Floor            Fax: (212) 754-6809
New York, NY 10022, U.S.A.
Attention: Michael Stout or John Thomas

A copy of all notices to Buyer shall be provided to the following attorneys:

Blank Rome LLP 405 Lexington Avenue, 23rd Floor New York, NY 10174
Attention: Robert J. Mittman Tel: (212) 885-5555 Fax: (212) 885-5001

(e) The provisions herein shall bind and inure to the benefit of the parties
hereto, the and their respective officers, directors, trustees, principals,
affiliates, heirs, executors, administrators, successors and assigns.

(f) This agreement is personal to the parties, and cannot be assigned by any act
of any party or by operation of law, without the express written consent of each
of the other parties, not to be unreasonably withheld.

(g) This agreement shall not be deemed to create a partnership, joint-venture,
agency, employee/employer or similar relationship between any of the parties.

(h) This agreement cannot be amended, modified or waived except in a writing
signed by the party having the obligation. The waiver by either party of any
instance of breach hereof shall not operate or be construed as a waiver of any
other instance of breach.

(i) Neither this agreement nor any provision hereof shall be construed against
any party on the ground that it was drafted by that party. To the maximum extent
possible, each provision hereof shall be interpreted so as to be valid and
effective under all applicable laws. If any provision is determined under any
applicable law to be prohibited or invalid, that provision shall be deemed
deleted and/or modified to the minimum extent necessary in order to bring it
into legal compliance consistent with the original intent of the parties.
Section headings herein are provided solely for convenient reference and shall
not be deemed to have any substantive effect.

IN WITNESS WHEREOF, the parties have executed this agreement as of the date
first set forth above.

OPTGENEX INC.

By: /s/ Richard S. Serbin
    -------------------------------
    Name: Richard Serbin
    Title: President

/s/ Pierre Apraxine
-----------------------------------
PIERRE APRAXINE

/s/ Micheal L.K. Hwang
-----------------------------------
MICHAEL L.K. HWANG, AS EXECUTOR
 OF THE ESTATE OF JOHN B. ELLIOTT

/s/ Anthony Christian Flood
-----------------------------------
ANTHONY CHRISTIAN FLOOD

/s/ Peter Koepke
-----------------------------------
PETER KOEPKEExhibit 10.1

--------------------------------------------------------------------------------

                            SHARE EXCHANGE AGREEMENT

                          dated as of January 31, 2006

                                  by and among

                               AVANTOGEN LIMITED,

                          BIOACCELERATE HOLDINGS, INC.

                                       and

                             INNOVATE ONCOLOGY, INC.

--------------------------------------------------------------------------------

<PAGE>

                                TABLE OF CONTENTS

                                                                            Page

1.   DEFINITIONS ...........................................................   1

2.   CLOSING ...............................................................   7

3.   REPRESENTATIONS AND WARRANTIES OF THE COMPANY .........................   8
     3.1      Due Organization .............................................   8
     3.2      Corporate Power; Authorization; Enforceable Obligation .......   8
     3.3      Capital Stock of the Company .................................   9
     3.4      Parent Affiliate Company Stock ...............................   9
     3.5      Ownership of Capital Stock of Gemini .........................   9
     3.6      Transactions in Capital Stock, Organization Accounting .......   9
     3.7      Subsidiaries .................................................  10
     3.8      Predecessor Status; etc ......................................  10
     3.9      Spin-off by the Company ......................................  10
     3.10     Company Public Reports; Financial Statements .................  10
     3.11     Accounts and Notes Receivable ................................  13
     3.12     Licenses .....................................................  13
     3.13     Tangible Personal Property ...................................  14
     3.14     Environmental Matters ........................................  14
     3.15     Intellectual Property ........................................  14
     3.16     Significant Customers; Company Contracts and Commitments .....  15
     3.17     Real Property ................................................  17
     3.18     Insurance ....................................................  17
     3.19     Compensation; Employment Agreements; Organized Labor Matters .  18
     3.20     Employee Plans ...............................................  18
     3.21     Conformity with Law; Litigation ..............................  19
     3.22     Taxes ........................................................  20
     3.23     No Violations; No Conflict; No Consents Required, Etc ........  23
     3.24     Absence of Changes ...........................................  23
     3.25     Deposit Accounts; Powers of Attorney .........................  25
     3.26     Relations with Governments ...................................  25
     3.27     No Interests In Other Businesses .............................  25
     3.28     Transactions With Affiliates .................................  26
     3.29     Condition and Sufficiency of Assets ..........................  26
     3.30     Takeover Statutes ............................................  26
     3.31     Dissenter's and Appraisal Rights .............................  27
     3.32     Disclosure ...................................................  27

4.   REPRESENTATIONS OF PARENT AND NEWCO ...................................  27
     4.1      Due Organization .............................................  27
     4.2      Corporate Power; Authorization; Enforceable Obligation .......  27
     4.3      Ownership of Gemini Stock ....................................  28
     4.4      Available Funds ..............................................  28
     4.5      No Violations; No Conflict; No Consents Required, Etc ........  28

                                       i
<PAGE>

     4.6      Compound Intellectual Property ...............................  28

5.   COVENANTS PRIOR TO CLOSING ............................................  29
     5.1      Access and Cooperation; Due Diligence ........................  29
     5.2      Conduct of Business Pending Closing ..........................  30
     5.3      Prohibited Activities ........................................  31
     5.4      No Solicitation ..............................................  34
     5.5      Notification of Certain Matters ..............................  35
     5.6      Proxy or Information Statement ...............................  36
     5.7      Company and Parent Shareholders Meeting; Board Recommendation   37
     5.8      Newco ........................................................  39
     5.9      Further Assurances ...........................................  39
     5.10     Joint Venture Agreement ......................................  39
     5.11     Takeover Statutes ............................................  39
     5.12     Dissenter's and Appraisal Rights .............................  39

6.   CONDITIONS PRECEDENT TO OBLIGATIONS OF THE COMPANY ....................  40
     6.1      Representations and Warranties; Performance of Obligations ...  40
     6.2      No Litigation ................................................  40
     6.3      Consents and Approvals .......................................  40
     6.4      No Material Adverse Effect ...................................  40
     6.5      Secretary's Certificate ......................................  40
     6.6      Contribution by Parent Affiliate .............................  40
     6.7      Resolution of Disputes .......................................  41
     6.8      Parent Shareholder Agreement .................................  41
     6.9      Noncompetition, Nondisclosure and Release Agreements .........  41
     6.10     Company Charter Documents; Voting Agreement ..................  41

7.   CONDITIONS PRECEDENT TO OBLIGATIONS OF PARENT, NEWCO AND GEMINI .......  41
     7.1      Representations and Warranties; Performance of Obligations ...  41
     7.2      No Litigation ................................................  42
     7.3      Consents and Approvals .......................................  42
     7.4      Good Standing Certificates ...................................  42
     7.5      No Material Adverse Effect ...................................  42
     7.6      Secretary's Certificate ......................................  42
     7.7      Noncompetition, Nondisclosure and Release Agreements .........  42
     7.8      Resolution of Disputes .......................................  42
     7.9      Company Shareholder Agreement ................................  42
     7.10     Registration Rights Agreement ................................  43
     7.11     Company Charter Documents ....................................  43
     7.12     FIRPTA .......................................................  43
     7.13     Filing of Form 10-KSB ........................................  43

8.   INDEMNIFICATION .......................................................  43
     8.1      Indemnification ..............................................  43
     8.2      Third Person Claims ..........................................  44
     8.3      Limitations on Indemnification ...............................  45
     8.4      Survival of Representations and Warranties ...................  46

                                       ii
<PAGE>

9.   TERMINATION OF AGREEMENT ..............................................  46
     9.1      Termination ..................................................  46
     9.2      Liabilities in Event of Termination ..........................  48

10.  COVENANTS POST-CLOSING ................................................  48
     10.1     Payment of Taxes .............................................  48
     10.2     Transfer Restrictions ........................................  48
     10.3     Registration of Parent Affiliate Company Stock ...............  49
     10.4     Cooperation on Tax Matters ...................................  49

11.  GENERAL ...............................................................  49
     11.1     Cooperation ..................................................  49
     11.2     Successors and Assigns .......................................  49
     11.3     Entire Agreement .............................................  49
     11.4     Counterparts .................................................  49
     11.5     Brokers and Agents ...........................................  50
     11.6     Expenses .....................................................  50
     11.7     Notices ......................................................  50
     11.8     Governing Law ................................................  51
     11.9     Jurisdiction and Venue .......................................  51
     11.10    Survival of Representations and Warranties ...................  51
     11.11    Exercise of Rights and Remedies ..............................  51
     11.12    Time .........................................................  51
     11.13    Reformation and Severability .................................  51
     11.14    Remedies Cumulative ..........................................  52
     11.15    Captions .....................................................  52
     11.16    Representation by Counsel ....................................  52
     11.17    Amendments; Waivers ..........................................  52
     11.18    Public Announcements .........................................  52

                                     ANNEXES

Annex I  -   Form of Parent Shareholder Agreement

Annex II -   Form of Company Shareholder Agreement

                                       iii
<PAGE>

                            SHARE EXCHANGE AGREEMENT

      THIS SHARE EXCHANGE AGREEMENT (the "Agreement") is made as of January 31,
2006 by and among Avantogen Limited, a corporation organized under the laws of
Australia ("Parent"), Bioaccelerate Holdings, Inc., a Nevada corporation
("Company Parent"), and Innovate Oncology, Inc., a Nevada corporation and a
subsidiary of Company Parent (the "Company").

                                    RECITALS

      WHEREAS, Resistys, Inc., a Delaware corporation ("Gemini") is a
corporation duly organized and existing under the laws of the State of Delaware,
and, as of the date of this Agreement, is a 50%-owned subsidiary of Parent and a
50%-owned subsidiary of the Company;

      WHEREAS, Parent may (i) transfer all of Parent's equity interests in
Gemini to a corporation which may be organized under the laws of the United
Kingdom and would be a wholly-owned subsidiary of Parent as of the date of
formation ("Newco"), and (ii) transfer to the shareholders of Parent all of
Parent's equity interests in Newco;

      WHEREAS, the parties hereto desire for Parent, directly or indirectly
through Newco or another Affiliate of Parent to transfer to the Company (i) all
of Parent's direct or indirect equity interest in Gemini (representing at such
time 50% of the equity interests in Gemini) and (ii) US$1,000,000 in cash; in
exchange for the Company issuing and delivering to Parent or Newco or another
Parent Affiliate (as defined below) 32 million shares of common stock, US$0.001
par value, of the Company ("Company Common Stock") out of an aggregate 59
million shares of Company Common Stock (there being no other class of capital
stock or rights to acquire other securities of the Company) on a Fully Diluted
Basis (as defined below).

      NOW, THEREFORE, in consideration of the premises and of the mutual
agreements, representations, warranties, provisions and covenants herein
contained, the parties hereto hereby agree as follows:

1.    DEFINITIONS

      Unless the context otherwise requires, capitalized terms used in this
Agreement or in any schedule attached hereto and not otherwise defined shall
have the following meanings for all purposes of this Agreement:

      "Account" has the meaning set forth in Section 2.

      "Accounts Receivable" has the meaning set forth in Section 3.11.

      "Acquisition Proposal" has the meaning set forth in Section 5.4.
<PAGE>

      "Adjustment Issuance" has the meaning set forth in Section 3.3.

      "Affiliate" means, with respect to any Person, any Person that directly,
or indirectly through one or more intermediaries, controls, is controlled by, or
is under common control with, such Person.

      "Agreement" has the meaning set forth in the preamble of this Agreement.

      "Business" means the promotion, development, testing, design, marketing,
provision or sale of any product designed or intended to do or assist with any
of the following: (i) to use antiviral agents to treat chemoresistance; (ii) to
suppress genes that counteract the effects of conventional chemotherapeutics; or
(iii) to serve as adjuvants to treat chemoresistance.

      "Business Day" means any day on which both the Federal Reserve Banks in
San Francisco, California and New York, New York are open for banking
operations.

      "Change in the Company Recommendation" has the meaning set forth in
Section 5.7.

      "Change in the Parent Recommendation" has the meaning set forth in Section
5.7.

      "Closing" has the meaning set forth in Section 2.

      "Closing Date" has the meaning set forth in Section 2.

      "Code" means the Internal Revenue Code of 1986, as amended.

      "Company" has the meaning set forth in the preamble of this Agreement.

      "Company Balance Sheet" has the meaning set forth in Section 3.10.

      "Company Balance Sheet Date" has the meaning set forth in Section 3.10.

      "Company Board" has the meaning set forth in Section 5.7.

      "Company Charter Documents" has the meaning set forth in Section 3.1.

      "Company Common Stock" has the meaning set forth in the recitals of this
Agreement.

      "Company Contracts" has the meaning set forth in Section 3.16.

      "Company Documents" has the meaning set forth in Section 3.2.

      "Company Filed Documents" has the meaning set forth in Section 3.23.

      "Company Financial Statements" has the meaning set forth in Section 3.10.

      "Company Indemnitees" has the meaning set forth in Section 8.1.

      "Company Intellectual Property" has the meaning set forth in Section 3.15.

                                       2
<PAGE>

      "Company Parent" has the meaning set forth in the recitals of this
Agreement.

      "Company Public Reports" has the meaning set forth in Section 3.10.

      "Company Recommendation" has the meaning set forth in Section 5.7.

      "Company Shareholder Approval" has the meaning set forth in Section 3.2.

      "Company Shareholders Meeting" has the meaning set forth in Section 5.6.

      "Company Stock" means the capital stock of the Company.

      "Company Written Consents" has the meaning set forth in Section 9.1.

      "Compound" has the meaning set forth in Section 2.

      "Compound Intellectual Property" has the meaning set forth in Section 4.6.

      "Confidentiality Agreement" has the meaning set forth in Section 5.1(c).

      "Copyrights" has the meaning set forth in Section 3.15.

      "Encumbrances" means all liens, security interest, pledges, charges,
voting agreements, voting trusts, equities, restrictions and other encumbrances
or other claims of any kind.

      "Environmental Laws" has the meaning set forth in Section 3.14.

      "ERISA" has the meaning set forth in Section 3.20.

      "ERISA Affiliate" has the meaning set forth in Section 3.20.

      "Exchange Act" means the Securities Exchange Act of 1934, as amended, and
the rules and regulations promulgated thereunder by the SEC.

      "Expiration Date" has the meaning set forth in Section 8.4.

      "FICA" has the meaning set forth in Section 3.22.

      "FIRPTA Certificate" has the meaning set forth in Section 3.22.

      "Fully Diluted Basis" means taking into consideration all capital stock
that is issued and outstanding on a particular date, plus all capital stock
which would be issued and outstanding assuming the exercise of all outstanding
options, warrants or other rights to purchase capital stock and the conversion
and exchange of all outstanding securities convertible into or exchangeable for
capital stock.

      "FUTA" has the meaning set forth in Section 3.22.

                                       3
<PAGE>

      "GAAP" means United States generally accepted accounting principles
applied on a consistent basis.

      "Gemini" has the meaning set forth in the recitals of this Agreement.

      "Gemini Stock" has the meaning set forth in Section 2.

      "Governmental Authority" has the meaning set forth in Section 3.21.

      "Hazardous Materials" has the meaning set forth in Section 3.14.

      "Hazardous Products" has the meaning set forth in Section 3.14.

      "Hazardous Substances" has the meaning set forth in Section 3.14.

      "Hazardous Wastes" has the meaning set forth in Section 3.14.

      "Indemnification Threshold" has the meaning set forth in Section 8.3.

      "Indemnified Party" has the meaning set forth in Section 8.2.

      "Indemnifying Parties" has the meaning set forth in Section 8.2.

      "Intellectual Property Rights" has the meaning set forth in Section 3.15.

      "Inventions" has the meaning set forth in Section 3.15.

      "Knowledge" means the actual knowledge of the officers of the applicable
party.

      "Laws" has the meaning set forth in Section 3.13.

      "Liability" or "Liabilities" means liabilities or obligations of any kind,
character or description, whether accrued, absolute, secured or unsecured,
contingent or otherwise, unless otherwise specified.

      "Licenses" has the meaning set forth in Section 3.12.

      "Loss" has the meaning set forth in Section 8.1.

      "Material Adverse Effect" means, with respect to any Person, a material
adverse effect on the business, operations, properties, assets, condition
(financial or otherwise) or results of operations of such Person, taken as a
whole.

      "Newco" has the meaning set forth in the recitals of this Agreement.

      "NOL" has the meaning set forth in Section 3.22.

      "Other Filings" has the meaning set forth in Section 5.6.

                                       4
<PAGE>

      "Parent" has the meaning set forth in the preamble of this Agreement.

      "Parent Affiliates" has the meaning set forth in Section 2.

      "Parent Affiliate Company Stock" has the meaning set forth in Section 2.

      "Parent Documents" has the meaning set forth in Section 4.2.

      "Parent Indemnifying Party" has the meaning set forth in Section 8.1.

      "Parent Indemnitees" has the meaning set forth in Section 8.1.

      "Parent Recommendation" has the meaning set forth in Section 5.7.

      "Parent Shareholder Approval" has the meaning set forth in Section 4.2.

      "Parent Shareholders Meeting" has the meaning set forth in Section 5.7.

      "Permitted Encumbrances" means (i) any lien for Taxes not yet due or
delinquent or Taxes being contested in good faith by appropriate proceedings and
properly reserved for in accordance with GAAP, (ii) any statutory lien arising
in the ordinary course of business by operation of law with respect to an
obligation or liability that is not yet due or delinquent, and (iii) any minor
imperfection of title or similar lien or encumbrance which individually or in
the aggregate with other imperfections of title, liens or encumbrances could not
reasonably be expected to have a Material Adverse Effect on the applicable
Person.

      "Person" means an individual or a corporation, limited partnership,
general partnership, limited liability company, trust, unincorporated
association, joint venture, association or government or any agency,
instrumentality or political subdivision thereof, or any other entity.

      "Proxy Statement" has the meaning set forth in Section 5.6.

      "Public Reports" has the meaning set forth in Section 3.10.

      "Record" means information that is inscribed on a tangible medium or that
is stored in an electronic or other medium and is retrievable in perceivable
form.

      "SEC" has the meaning set forth in Section 3.10.

      "Securities Act" means the Securities Act of 1933, as amended, and the
rules and regulations promulgated thereunder by the SEC.

      "SOXA" has the meaning set forth in Section 3.10.

      "Subsidiary" means, as to any Person, any Person other than an individual,
50% or more of the shares of voting stock (or in the case of such a Person which
is not a corporation, 50% or more of the equity interests that provide the power
to manage, elect the management or direct the management of such Person) of
which is at the time any determination is being made, owned or controlled,
directly or indirectly, by such Person and its wholly owned Subsidiaries.
Notwithstanding the foregoing, with reference to Parent, Newco, Parent
Affiliates, the Company Parent and Company the term "Subsidiary" does not
include Gemini; instead, where representations, warranties, covenants and
agreements or closing conditions applicable to Parent, Newco, Parent Affiliates,
the Company Parent or the Company are meant to apply to Gemini, Gemini is
referred to by name, rather than as a "Subsidiary."

                                       5
<PAGE>

      "Superior Proposal" means (i) with respect to the Company, any bona fide
written offer that is not subject to any conditions to the parties' obligation
to consummate the transaction (other than conditions that are in the aggregate
as likely to result in the consummation of such transaction as the aggregate of
the conditions contained in this Agreement) made by a third party in respect of
a transaction (or series of related transactions) that if consummated would
result in such third party (or in the case of a direct merger between such third
party and the Company or one of its Subsidiaries, the shareholders of such third
party) acquiring, directly or indirectly, at least 50% of the voting power of
the Company or at least 50% of the assets of the Company and its Subsidiaries,
taken as a whole, which transaction the Company Board determines in its good
faith judgment (after consultation with a reputable financial advisor) (taking
into account the person making the offer, the consideration offered, the
likelihood of consummation (including the legal, financial and regulatory
aspects of the offer) as well as any other factors deemed relevant by the
Company Board) to be more favorable from a financial point of view to the
shareholders of the Company than the transactions contemplated by this
Agreement, taking into account any changes to the terms of this Agreement
offered by Parent in accordance with Section 9.1(j) in response to notice from
the Company of such Superior Proposal and (ii) with respect to Parent, Newco or
Gemini, any bona fide written offer that is not subject to any conditions to the
parties' obligation to consummate the transaction (other than conditions that
are in the aggregate as likely to result in the consummation of such transaction
as the aggregate of the conditions contained in this Agreement) made by a third
party in respect of a transaction (or series of related transactions) that if
consummated would result in such third party (or in the case of a direct merger
between such third party and Parent, Newco or Gemini or one of their respective
Subsidiaries, the shareholders of such third party) acquiring, directly or
indirectly, 50% of the voting power of Parent, Newco or Gemini or at least 50%
of the assets of Parent, Newco or Gemini, which transaction the Board of
Directors of Parent determines in its good faith judgment (after consultation
with a reputable financial advisor) (taking into account the person making the
offer, the consideration offered, the likelihood of consummation (including the
legal, financial and regulatory aspects of the offer) as well as any other
factors deemed relevant by the Board of Directors of Parent) to be more
favorable from a financial point of view to the shareholders of Parent than the
transactions contemplated by this Agreement, taking into account any changes to
the terms of this Agreement offered by Company Parent and the Company in
accordance with Section 9.1(i) in response to notice from Parent of such
Superior Proposal.

      "Tax" or "Taxes" has the meaning set forth in Section 3.22.

      "Tax Returns" has the meaning set forth in Section 3.22.

      "Third Person" has the meaning set forth in Section 8.2.

      "Use" or "Uses" has the meaning set forth in Section 3.15.

                                       6
<PAGE>

2. CLOSING

      The consummation of the transactions contemplated by this Agreement (the
"Closing") shall take place on or before April 24, 2006, or as promptly
thereafter as the conditions to the Closing may have been satisfied or waived by
the appropriate Person or Persons (the "Closing Date"), at the offices of Kaye
Scholer LLP, 1999 Avenue of the Stars, Suite 1700, Los Angeles, California
90067. On the Closing Date, the following shall occur and be completed as part
of one concurrent transaction:

            (a) Parent or Newco or an Affiliate of either (collectively, "Parent
Affiliates") shall transfer to the Company all of its capital stock of Gemini
(the "Gemini Stock") by delivering to the Company certificates representing the
Gemini Stock, duly endorsed (or accompanied by duly executed stock powers) for
transfer to the Company or, if the applicable certificate is lost, stolen,
mutilated or destroyed, an affidavit of loss with respect thereto;

            (b) Parent shall deliver, or shall cause a Parent Affiliate to
deliver to the Company US$1,000,000 by wire transfer of immediately available
funds to the Company account designated by the Company, which account shall be
designated at least two Business Days prior to the Closing (the "Account");

            (c) Parent shall deliver, or shall cause a Parent Affiliate to
deliver to the Company either (i) an additional US$100,000 by wire transfer of
immediately available funds to the Account or (ii) the intellectual property
owned by or licensed to a Parent Affiliate with respect to an additional
oncology related compound or technology (the "Compound"), such selection to be
made at the Parent Affiliate's sole discretion, subject to Section 5.1(b);

            (d) The Company shall issue and deliver to the transferor of the
Gemini Stock pursuant to clause (a) above 32,000,000 shares of Company Common
Stock, which shall represent at and immediately after Closing at least a 54.24%
equity interest in the Company on a Fully Diluted Basis (the "Parent Affiliate
Company Stock");

            (e) The Company Charter Documents shall be amended and restated in a
form and in substance reasonably satisfactory to Company Parent and Parent to
reflect, among other things, (i) that the Nevada Revised Statutes "Combinations
with Interested Stockholder," "Acquisition of Controlling Interests" and similar
provisions do not apply to the transaction contemplated by this Agreement or to
Parent, Newco or their respective Affiliates and (ii) restrictions on actions by
Company post-Closing without the approval of Company Parent so long as Company
Parent owns 20% or more of the capital stock of the Company on a Fully Diluted
Basis, and such other matters, if any, as may be mutually agreed by Company
Parent and Parent, unless as to item (ii), the Company Parent and Parent agree
to address such matters in a voting agreement;

            (f) The members of the Company Board immediately prior to the
Closing shall resign or be removed and replaced by Dr. Richard Opara, two
individuals nominated by the Company and two individuals nominated by Dr.
Richard Opara, each of whom will serve until such time as he or she resigns or
is removed or replaced pursuant to the Certificate of Incorporation and Bylaws
of the Company, and with Dr. Opara serving as Chairman of the Board immediately
upon Closing); and

                                       7
<PAGE>

            (g) The officers of the Company immediately prior to the Closing
shall resign or be removed as officers of the Company, with no further
obligations to or from the Company.

3. REPRESENTATIONS AND WARRANTIES OF THE COMPANY

      Except as set forth on a Schedule attached hereto prior to the execution
and delivery of this Agreement corresponding to the section of this Agreement to
which any representations and warranties specifically relate, the Company Parent
and the Company each hereby represents and warrants to Parent, Newco and all
Parent Affiliates as follows:

      3.1 Due Organization. The Company Parent, the Company and each Subsidiary
of the Company are each a corporation duly organized, validly existing and in
good standing under the laws of the State of Nevada, and having the requisite
power and authority to carry on its respective business as it is now being
conducted and as currently proposed to be conducted. The Company Parent, the
Company and each Subsidiary of the Company are each duly qualified to do
business and are in good standing in its state of incorporation, which is the
only jurisdiction in which the nature of its business or the ownership or
leasing of its properties makes such qualification necessary, except for such
jurisdictions where the failure to be so authorized or qualified would not have
a Material Adverse Effect on the Company. True, complete and correct copies of
the Articles of Incorporation and Bylaws, each as amended through the date
hereof, of the Company (the "Company Charter Documents") have been delivered or
made available to Parent and Newco. The Company has delivered or made available
to Parent and Newco true, complete and correct copies of the stock records of
the Company and each Subsidiary of the Company and all minutes of meetings and
written consents and other evidence, if any, of deliberations of or actions
taken by the Company's Board of Directors, any committees thereof and/or
shareholders since August 31, 2004 and, to the Knowledge of the Company, since
the Company's inception, and those of each Subsidiary of the Company since
August 31, 2004 and, to the Knowledge of the Company, since such Subsidiary's
inception.

      3.2 Corporate Power; Authorization; Enforceable Obligation. Each of the
Company Parent and the Company has the full legal right, power and authority to
execute and deliver this Agreement, to perform its obligations hereunder, and to
consummate the transactions contemplated hereby. The execution, delivery and
performance of this Agreement and the consummation of the transactions
contemplated hereby have been duly and validly authorized by the approval of the
Boards of Directors of the Company Parent and the Company and, with respect to
the Company upon approval of the shareholders of the Company ("Company
Shareholder Approval"), no further corporate action on the part of the Company
Parent or the Company is necessary to authorize this Agreement or the other
agreements, documents, certificates and instruments required to be delivered
hereby or the performance of the transactions contemplated hereby. This
Agreement and the other agreements, documents, certificates and instruments
required to be delivered by the Company Parent and/or the Company in accordance
with the provisions hereof (the "Company Documents") will be duly executed and
delivered by the Company Parent and/or the Company, as applicable, by duly
authorized officers and this Agreement constitutes, and the Company Documents
when executed and delivered will constitute, the legal, valid and binding
obligations of the Company Parent and the Company, enforceable against them in
accordance with their respective terms.

                                       8
<PAGE>

      3.3 Capital Stock of the Company. As of December 31, 2005, the authorized
capital stock of the Company consists only of 25,000,000 shares of preferred
stock, of which none are issued and outstanding and 125,000,000 shares of common
stock, US$0.001 par value, 18,178,242 of which are issued and outstanding on a
Fully Diluted Basis. All of the issued and outstanding shares of Company Stock
have been duly authorized and validly issued, are fully paid and nonassessable.
All such shares were offered, issued and sold by the Company in compliance with
all applicable federal and state securities or blue sky laws, and none of such
shares are subject to, nor were they issued in violation of any preemptive or
stock purchase rights, of any past or present shareholder. There are no voting
agreements or voting trusts of which the Company has Knowledge with respect to
any of the outstanding shares of Company capital stock. Notwithstanding the
foregoing the parties hereby acknowledge and agree that immediately prior to
Closing, Company will have taken actions such that no more than 27,000,000
shares of Company Common Stock shall be issued and outstanding on a Fully
Diluted Basis, and at Closing an additional 32,000,000 shares of Company Common
Stock shall be issued to the transferor of the Gemini Stock to the Company. The
issuance of additional shares of Company Common Stock to increase the
outstanding to 27,000,000 is sometimes hereafter referred to as the "Adjustment
Issuance." The issuance of 32,000,000 shares of Company Common Stock at Closing
is sometimes hereafter referred to as the "Closing Issuance."

      3.4 Parent Affiliate Company Stock. At the time of issuance thereof and
delivery in accordance with the terms hereof, the Parent Affiliate Company Stock
to be delivered pursuant to Section 2 shall constitute valid and legally issued
and fully paid shares of Company Common Stock representing at least a 54.24%
equity interest in the Company on a Fully Diluted Basis, and shall be identical
in all respects as to rights and privileges thereof to the Company Common Stock
issued and outstanding as of the date hereof, except to the extent of any
restrictions on resale set forth in Section 10.2 hereof or under applicable
securities laws. Except as set forth herein and in Section 10.2 hereof, the
Parent Affiliate Company Stock issued and delivered pursuant to Section 2 shall
at the time of such issuance and delivery be free and clear of any Encumbrances
other than those created by Newco or Parent.

      3.5 Ownership of Capital Stock of Gemini. The Company is the record and
beneficial owner of 50% of the Gemini Stock and will, immediately prior to the
Closing, be the record and beneficial owner of such stock, free and clear of any
Encumbrances other than any Encumbrances arising through the agreements for the
establishment of Gemini and between the shareholders therein.

      3.6 Transactions in Capital Stock, Organization Accounting. Except as set
forth in the Company Public Reports, there are no authorized or outstanding
options, warrants, calls, rights, subscriptions, claims of any character,
agreements, obligations, convertible or exchangeable securities, or other
commitments (contingent or otherwise) relating to Company Stock or any equity
interest in any Subsidiary pursuant to which the Company or any such Subsidiary
is or may become obligated to issue shares of common stock, or any other shares
of its capital stock or any securities convertible into, exchangeable for, or
evidencing the right to subscribe for or otherwise acquire, any shares of
Company Stock or equity interest in any such Subsidiary. Except as set forth in
the Company Public Reports, the Company has no commitments or obligations
(contingent or otherwise) to purchase, redeem or otherwise acquire any of its
securities or any interests therein or to pay any dividend or make any
distribution in respect thereof.

                                       9
<PAGE>

      3.7 Subsidiaries. Except as set forth in Schedule 3.7, the Company has no,
and to the Knowledge of the Company, except as set forth in the Public Reports,
has never had any, Subsidiaries other than Gemini. Except as set forth in
Schedule 3.7, the Company does not presently own, of record or beneficially, or
control, directly or indirectly, any capital stock or other equity interest or
securities convertible into, exchangeable or exercisable for, or evidencing the
right to subscribe for or otherwise acquire, capital stock or any other equity
interest in any Person. The Company owns all equity interests in each
Subsidiary.

      3.8 Predecessor Status; etc. Since August 31, 2004, except as set forth on
Schedule 3.8 or in the Company Public Reports, there are, and for all periods
prior to August 31, 2004, to the Knowledge of the Company except as set forth in
Public Reports there are, (i) no predecessor companies of the Company or any
Subsidiary, and (ii) no Person which has been acquired by the Company (by stock
purchase, merger or otherwise) or from which the Company previously acquired all
or substantially all of any such Person's assets (or all or substantially all of
the assets used by any such Person in any line of business). Since August 31,
2004, except as set forth on Schedule 3.8 or in the Company Public Reports, the
Company has not been, and for all periods prior to August 31, 2004, to the
Knowledge of the Company except as set forth in the Public Reports the Company
was not, a Subsidiary or division of another Person other than Company Parent or
a part of an acquisition which was later rescinded.

      3.9 Spin-off by the Company. Since August 31, 2004, except as set forth in
the Company Public Reports, and, to the Knowledge of the Company, with respect
to all periods prior to August 31, 2004 except as set forth in Public Reports,
there has not been any sale, spin-off or split-up of the Company or of any
material assets of the Company.

      3.10 Company Public Reports; Financial Statements.

            (a) All forms, statements, schedules, reports and documents
(including items incorporated by reference) required to be filed by the Company
with the Securities and Exchange Commission ("SEC") and any other applicable
Governmental Authority (including those that the Company may file subsequent to
the date of this Agreement) are referred to herein as the "Public Reports." Such
Public Reports filed since August 31, 2004, including those that the Company may
file subsequent to the date of this Agreement, are sometimes hereafter referred
to as Company Public Reports. The Company has filed all Public Reports required
to be filed by the Company with the Securities and Exchange Commission ("SEC")
and any other applicable Governmental Authority since August 31, 2003, and all
such forms, statements, schedules, reports and documents in the form filed with
the SEC or such other Governmental Authorities are available to Parent or have
been made available to Parent by the Company. As of their respective dates, the
Company Public Reports (i) complied as to form in all material respects with the
requirements of the SEC and such other Governmental Authorities, and the rules
and regulations of the SEC and such other Governmental Authorities applicable to
such Company Public Reports and (ii) did not at the time they were filed contain
any untrue statement of a material fact or omit to state a material fact
required to be stated therein or necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not
misleading, except to the extent corrected (A) in the case of Company Public
Reports filed prior to the date of this Agreement that were amended or
superseded prior to the date of this Agreement, by the filing of such amending
or superseding Company Public Report and (B) in the case of Company Public
Reports filed after the date of this Agreement that are amended or superseded
prior to the Closing Date, by the filing of such amending or superseding Company
Public Report. No Subsidiary of the Company is required to file any forms,
reports or other documents with the SEC or any other Governmental Authority.

                                       10
<PAGE>

            (b) As of their respective dates, each of the consolidated financial
statements (including, in each case, any related notes thereto) contained in the
Company Public Reports (the "Company Financial Statements"), (i) complied as to
form in all material respects with the published rules and regulations of the
SEC with respect thereto, (ii) was prepared in accordance with GAAP (except as
may be indicated in the notes thereto or, in the case of unaudited interim
financial statements, as may be permitted by the SEC on Form 10-Q, Form 8-K or
any successor form under the Exchange Act), and (iii) fairly presented in all
material respects, on a consolidated basis as required in accordance with GAAP,
the financial position of the Company and its Subsidiaries (including for
purposes of this clause (iii), to the extent applicable under GAAP, Gemini) as
at the respective dates thereof and the results of Company's and its
Subsidiaries' operations and cash flows for the periods indicated, except that
the unaudited interim financial statements may not contain footnotes and were or
are subject to normal and recurring year-end adjustments in accordance with GAAP
and any other exceptions noted therein, except to the extent corrected (A) in
the case of Company Financial Statements filed prior to the date of this
Agreement that were amended or superseded prior to the date of this Agreement by
the filing of such amending or superseding Company Financial Statements and (B)
in the case of Company Public Reports filed after the date of this Agreement
that are amended or superseded prior to the Closing Date by the filing of such
amending or superseding Company Financial Statements, if any. The balance sheet
of the Company as of September 30, 2005 (the "Company Balance Sheet Date")
contained in the Company Public Reports is hereinafter referred to as the
"Company Balance Sheet." At the Closing Date, neither the Company nor any of its
Subsidiaries has or will have any Liabilities required under GAAP to be set
forth on a balance sheet, except for any contractual obligations under the
Company Contracts which are to be performed after the Closing Date in accordance
with the terms of those Company Contracts (it being understood that any
outstanding payment obligations under the Joint Venture Agreement (as defined
below) with respect to Gemini to have been performed prior to the Closing in
accordance with its terms are to have been performed by Parent prior to Closing,
rather than by Parent and Company Parent, and are excluded from this
representation and warranty). Neither the Company nor any of its Subsidiaries is
a party to any off-balance sheet arrangements (as defined in Item 303 of
Regulation S-K). Since August 31, 2004, the Company has not had any disagreement
with any of its auditors regarding accounting matters or policies during any of
its past three full fiscal years or during the current fiscal year-to-date.
Since August 31, 2004, the books and records of the Company and each of its
Subsidiaries have been maintained, and are being maintained, in all material
respects in accordance with applicable legal and accounting requirements, and
the Company Financial Statements are consistent in all material respects with
such books and records.

                                       11
<PAGE>

            (c) No investigation by the SEC with respect to the Company or any
of its Subsidiaries is pending or, to the Knowledge of the Company, threatened.

            (d) The Company has established and maintains "disclosure controls
and procedures" (as defined in Rules 13a-15(e) and 15d-15(e) promulgated under
the Exchange Act) that are reasonably designed to ensure that material
information (both financial and non-financial) relating to the Company and its
Subsidiaries required to be disclosed by the Company in the Company Public
Reports that it files or submits under the Exchange Act is communicated to the
Company's principal executive officer and principal financial officer, or
persons performing similar functions, as appropriate to allow timely decisions
regarding required disclosure and to make the certifications of the principal
executive officer and the principal financial officer of the Company required by
Section 302 of the Sarbanes-Oxley Act of 2002 ("SOXA") with respect to such
reports. For purposes of this Agreement, "principal executive officer" and
"principal financial officer" shall have the meanings given to such terms in
SOXA. Each of the principal executive officer of the Company and the principal
financial officer of the Company (or each former principal executive officer of
the Company and each former principal financial officer of the Company, as
applicable) has made all certifications required by Sections 302 and 906 of SOXA
and the rules and regulations promulgated thereunder with respect to the Company
Public Reports.

            (e) The Company maintains a system of internal accounting controls
designed to provide reasonable assurance that (i) transactions are executed in
accordance with management's general or specific authorizations, (ii)
transactions are recorded as necessary to permit preparation of financial
statements in conformity with GAAP and to maintain asset accountability, (iii)
access to assets is permitted only in accordance with management's general or
specific authorization, and (iv) the recorded accountability for assets is
compared with the existing assets at reasonable intervals and appropriate action
is taken with respect to any differences. The Company has made available to
Parent and Newco accurate and complete copies of all material policies, manuals
and other documents promulgating such internal accounting controls appropriate
to an entity such as the Company and consistent with applicable Laws. Except as
set forth in Schedule 3.10(e), to the Company's Knowledge, there are no
"material weaknesses" (as defined by the Public Company Accounting Oversight
Board) and there are no series of multiple "significant deficiencies" (as
defined by the Public Company Accounting Oversight Board) that are reasonably
likely to collectively represent a "material weakness" in the design or
operation of the Company's internal controls and procedures, and to the
Company's Knowledge, as of the date of this Agreement there are no significant
deficiencies, in the design or operation of the Company's internal controls and
procedures. To the Company's Knowledge, there has been no fraud that involves
management or other employees who have a significant role in the Company's
internal controls and procedures.

            (f) To the Company's Knowledge, Cacciamatta Accountancy Corporation,
which has expressed its opinion with respect to the financial statements of the
Company and its Subsidiaries as of December 31, 2003 and December 31, 2004 and
for each of the years in the three-year period ended December 31, 2004 included
in the Company Public Reports (including the related notes), is "independent"
with respect to the Company and its Subsidiaries within the meaning of
Regulation S-X and has been "independent" within such meaning at all times since
December 31, 2001. The Company has made such disclosure of non-audit services
performed by Cacciamatta Accountancy Corporation in its proxy statements with
respect to its annual meetings of shareholders as is required under the rules
and regulations of the SEC, and all such non-audit services have been approved
in advance by the audit committee of the Company's Board of Directors. The
Company is in compliance with the applicable criteria for continued listing of
the Company Stock on the OTC Bulletin Board.

                                       12
<PAGE>

            (g) The Proxy Statement and any Other Filings, and any amendments or
supplements thereto, at (i) the time such Proxy Statement is first mailed to the
Company's shareholders, (ii) the time of the related meeting or meetings of the
shareholders of the Company, and (iii) the Closing, will comply as to form in
all material respects with the applicable requirements of the Securities Act,
the Exchange Act and other applicable Laws.

            (h) The Proxy Statement and any Other Filings, and any amendments or
supplements thereto, do not, and will not, at (i) the time such Proxy Statement
is first mailed to the Company's shareholders, (ii) the time of the related
meeting or meetings of the shareholders of the Company, and (iii) the Closing,
contain any untrue statement of a material fact or omit to state any material
fact required to be stated therein or necessary in order to make the statements
made therein, in light of the circumstances under which they were made, not
misleading. Notwithstanding the foregoing, no representation or warranty is made
by the Company with respect to statements made or incorporated by reference
therein about Parent or Newco or their respective businesses or assets supplied
by Parent or Newco for inclusion or incorporation by reference in the Proxy
Statement.

      3.11 Accounts and Notes Receivable. The Company Balance Sheet sets forth a
true, complete and correct list of the accounts and notes receivable of the
Company as of September 30, 2005 and including receivables from and advances to
employees and the shareholders of the Company, which are identified as such
(collectively, the "Accounts Receivable") and such aggregate amounts have not
changed in any material manner. The Company's management reasonably believes
that the Accounts Receivable and all accounts receivable incurred thereafter are
and will be collectible in the amounts shown on the Company Balance Sheet and in
the Company's books and records, net of reserves reflected in the Balance Sheet
(which reserves are adequate and calculated in accordance with GAAP). All
Accounts Receivable and all accounts receivable incurred thereafter represent
legal, valid and binding obligations arising from bona fide business
transactions in the ordinary course of business consistent with past practices.
There is no contest, claims, counterclaims, defense, or other right of set-off,
other than returns in the ordinary course consistent with the past practices.

      3.12 Licenses. The Company and its Subsidiaries each holds all licenses,
franchises, permits and other governmental authorizations necessary for the
continued operation of their respective businesses, as they are currently being
conducted and currently proposed to be conducted ("Licenses"), except for those
the failure to hold do not and would not reasonably be expected to, individually
or in the aggregate, have a Material Adverse Effect on the Company, if any, and
the Company Public Reports include summary descriptions of all such Licenses to
the extent required under applicable law. Such Licenses are valid and in full
force and effect and the transactions contemplated by this Agreement will not
result in a default under or a breach or violation of, or adversely and
materially affect the rights and benefits afforded to the Company by, any such
Licenses or other rights or its Subsidiaries.

                                       13
<PAGE>

      3.13 Tangible Personal Property. All material tangible personal property
used by the Company or its Subsidiaries in their respective businesses (i) is
either owned by the Company or any applicable Subsidiary or leased by the
Company or any applicable Subsidiary pursuant to a lease listed on Schedule
3.13, (ii) is in reasonable working order and condition, ordinary wear and tear
excepted, (iii) is usable in the regular and ordinary course of the Company's
business as presently conducted, and (iv) conforms to all applicable federal,
state, local and foreign statutes (civil and criminal), laws, ordinances,
regulations, codes, rules, permits, judgments, orders and decrees (collectively,
"Laws") relative to their construction, use and operation, in each case under
items (iii) and (iv) except as has not and would not individually or in the
aggregate have a Material Adverse Effect on the Company. All leases and
agreements listed on Schedule 3.13 are in full force and effect and constitute
the legal, valid and binding agreements of the Company or its Subsidiaries and,
to the Companies knowledge, the other parties (and their successors) thereto in
accordance with their respective terms.

      3.14 Environmental Matters. The Company and its Subsidiaries, in each case
except as does not have a Material Adverse Effect on the Company, has (i)
complied with and is in compliance with all Laws applicable to it or any of its
properties, assets, operations, and businesses relating to environmental
protection (collectively "Environmental Laws") including, without limitation,
Environmental Laws relating to air, water, land and the generation, storage,
use, handling, transportation, treatment or disposal of Hazardous Wastes,
Hazardous Materials and Hazardous Substances (as such terms are defined in any
applicable Environmental Law), as well as petroleum and petroleum products
(collectively "Hazardous Products"), (ii) has obtained and is in compliance with
all Licenses and other approvals required by applicable Environmental Laws which
are necessary for the Company's or any Subsidiary's operations, a list of all of
which Licenses and approvals is set forth on Schedule 3.14, and (iii) has
reported to the appropriate authorities, to the extent required by all
Environmental Laws, all past and present sites owned and operated by the Company
or any Subsidiary where Hazardous Products have been generated, stored, used,
treated, disposed of or otherwise handled. There have been no releases or
threats of releases (as these terms are defined in Environmental Laws) of any
Hazardous Products at, from, in or on any property owned or operated by the
Company or any Subsidiary, and there is no on-site or off-site location to which
the Company or any Subsidiary has transported or disposed of Hazardous Products
or arranged for the transportation or disposal of Hazardous Materials which is
the subject of any federal, state, local or foreign enforcement action or any
other investigation or which could reasonably be expected to lead to any claim
against the Company, Parent or Newco for any clean-up cost, remedial work,
damage to natural resources, property damage or personal injury, including, but
not limited to, any claim under applicable Environmental Laws.

      3.15 Intellectual Property.

            (a) The Company and each Subsidiary owns or has licensed (under
valid and continuing licenses) all Intellectual Property Rights (as defined
below) that the Company or any Subsidiary uses, exercises or exploits ("Uses" or
"Use") in its business as is currently conducted and currently proposed to be
conducted (the "Company Intellectual Property") free of all Encumbrances
(except, in respect of licenses, for the Encumbrances pursuant to the licenses
themselves) and a true, complete and correct list of such Company Intellectual
Property is set forth in Schedule 3.15, other than any Company Intellectual
Property that is not material to the Company or any Subsidiary or is readily
obtainable from commercial sources. To the Company's Knowledge, the Company
Intellectual Property and the use thereof does not and will not infringe or
otherwise violate the copyrights, domain name rights, trademark rights, patent
rights, trade secrets, confidentiality rights or any other rights (including,
without limitation, Intellectual Property Rights) of any Person in any country.
No Company Intellectual Property was conceived or developed directly or
indirectly with government funding or pursuant to a government contract. To the
Company's Knowledge, there is and has been no unauthorized Use, disclosure,
infringement or misappropriation of any Company Intellectual Property by any
Person, including, without limitation, any employee, former employee,
independent contractor or former independent contractor of the Company or any
Subsidiary. The Company has taken appropriate steps to protect and preserve the
confidentiality of all Company Intellectual Property.

                                       14
<PAGE>

            (b) "Intellectual Property Rights" means (a) works of authorship
protected or protectable under the copyright laws of the United States and all
other countries for the full terms thereof (including all rights accruing by
virtue of copyright treaties and conventions), including but not limited to all
renewals, extensions, reversions or restorations of copyrights now or hereafter
provided by Law ("Copyrights"); (b) new and useful inventions, patent
applications and letters patent in the United States and all other countries and
continuations and divisions thereof and ("Inventions"); (c) all trade names,
trademarks, service marks, logos, trade dress, domain names and designs and all
goodwill in connection therewith ("Trademarks"); and (d) trade secrets,
confidential or proprietary information and know-how. There are no pending
claims, actions, suits or other proceedings against the Company or any
Subsidiary or their respective assets, businesses or properties before any
tribunal involving a claim of infringement or violation of any Person's
Intellectual Property Rights and the Company has not received notice of any
claim of such infringement and to the Knowledge of the Company there is no basis
for such claims. All Copyrights within the Company Intellectual Property have
been created by persons who were employees of the Company at the time of the
creation of the copyrighted work, or have been assigned to the Company or were
created by independent contractors as work for hire under the copyright laws of
the United States. All Inventions within the Company Intellectual Property have
been created by persons who were employees of the Company at the time of the
Invention, or otherwise in compliance with all applicable Laws, or have been
licensed or irrevocably assigned to the Company. The Company has not assigned or
licensed any Copyrights, Inventions, or Trademarks to any third party.

      3.16 Significant Customers; Company Contracts and Commitments.

            (a) Schedule 3.16 contains a true, complete and correct list of the
five (5) largest customers of the Company (measured by the amount of the
Company's revenues attributable to such customers) during the 12-month period
ended on the Balance Sheet Date. None of the customers listed in Schedule 3.16
has informed the Company that it intends to stop, or materially decrease the
rate of, purchasing materials, products or services from the Company which could
reasonably be expected to result in a Material Adverse Effect on the Company.

            (b) The Company Public Reports identify and include copies of all
Company Contracts (as defined below) to which the Company or any Subsidiary is a
party or by which it or any of their respective properties or assets are bound
that are required to be identified and filed in the Company Public Reports under
applicable law. All of the Company Contracts are in full force and effect and
constitute the legal, valid and binding agreements of the Company or any
Subsidiary and, to the Company's Knowledge, the other parties thereto in
accordance with their respective terms. Neither the Company nor the shareholders
of the Company nor any other party thereto is in breach or default, and no event
has occurred which with notice or lapse of time would constitute a breach or
default, or permit termination, modification or acceleration under any Company
Contract, except as has not and would not, individually or in the aggregate,
have a Material Adverse Effect on the Company. For purposes of this Agreement,
the phrase "Company Contracts" means (i) all Company Filed Documents and (ii)
any of the following contracts, agreements, arrangements, commitments or
understandings, written or oral, to which the Company or any Subsidiary is a
party or by which it or any of their respective properties, businesses or assets
are bound:

                                       15
<PAGE>

                  (i) any agreement, contract, commitment, arrangement or
understanding between the Company or any Subsidiary and any other Person,
including any mortgage, indenture, security agreement or similar item, for which
the Company or any Subsidiary has an aggregate future Liability or receivable,
which aggregate future Liability or receivable is specified by terms of the
contract is to be in excess of US$50,000 in any 12-month period;

                  (ii) any agreement, contract, commitment, arrangement or
understanding with any present or future employee, independent contractor or
consultant or for the employment of any person, including any consultant, which
is not terminable on not more than thirty (30) days notice and without penalty
or payment of amounts other than amounts earned through the date of termination;

                  (iii) joint venture or partnership agreements, strategic
alliances agreements or agreements, contracts, commitments, arrangements or
understandings with respect to any similar relationships;

                  (iv) contracts with any labor organization;

                  (v) contracts or options to purchase land;

                  (vi) any agreement, contract, commitment, arrangement or
understanding containing purchase requirements or "take or pay" provisions;

                  (vii) any agreement, contract, commitment, arrangement or
understanding containing a provision to indemnify any person or entity (other
than any non-disclosure agreement entered into by the Company in the ordinary
course of its business, requiring, as to indemnification, only the
indemnification by the Company for a breach of the non-disclosure,
non-retention, non-use and non-solicitation duties thereunder) or assume any
tax, environmental or other Liability or obligation;

                  (viii) any agreement, contract, commitment, arrangement or
understanding limiting or restraining the Company or any Subsidiary or any
successor to any of the foregoing, all shareholders of the Company or any
Subsidiary, or any employee of the Company or any Subsidiary or any successor
thereto, from engaging or competing in any manner or in any business other than
restrictions in favor of the Company or any Subsidiary itself (and other than
any non-disclosure agreement entered into by the Company in the ordinary course
of its business which limits or restrains only the disclosure, retention or use
of such other Person's confidential or proprietary information covered thereby
and sometimes contains non-solicitation provisions related thereto);

                                       16
<PAGE>

                  (ix) any license, franchise, distributorship or other
agreement, contract, commitment, arrangement or understanding which relates in
whole or in part to any software (other than off-the-shelf software costing less
than US$750 for any single license), patent, trademark, trade name, service
mark, or copyright or to any ideas, technical assistance or other know-how of or
used by the Company or any Subsidiary;

                  (x) any agreement, contract, commitment, arrangement or
understanding to which the Company or any Subsidiary, on the one hand, and any
Affiliate, officer, director or shareholder of the Company, on the other hand,
are parties;

                  (xi) any material agreement, contract, commitment arrangement
or understanding not made in the ordinary course of business; and

                  (xii) any other agreements, contracts, commitments,
arrangements or understandings which are not terminable on thirty (30) days or
less notice and specify contractually required payments by the Company in any
12-month period in excess of US$50,000.

            (c) Neither the Company nor any Subsidiary has any current plans or
projects involving the opening of new operations, expansion of existing
operations, or the acquisition of any personal property, business or assets
requiring, in any event, the payment of more than US$50,000 by the Company or
any Subsidiary during any 12-month period other than (i) pursuant to this
Agreement, or (ii) with respect to the development of its Intellectual Property
Rights pursuant to its existing contractual obligations, or (iii) with respect
to the development of new Intellectual Property Rights which it may acquire as
to which plans for new Intellectual Property Rights the Company has provided a
schedule to Parent.

      3.17 Real Property. Schedule 3.17 includes a true, complete and correct
list of all real property leased by the Company or any Subsidiary at the date
hereof and all other real property, if any, used by the Company in the conduct
of its business, and not specifically identified in the Company Public Reports.
True, complete and accurate copies of all such leases and agreements have been
made available to Parent. Neither the Company nor any Subsidiary owns any real
property. Except as identified in Schedule 3.17, none of the properties listed
on Schedule 3.17 are currently owned by the officers, directors or shareholders
of the Company or Affiliates of the Company except as disclosed on Schedule
3.17. All of such leases included on Schedule 3.17 are in full force and effect
and constitute the legal, valid and binding agreements of the Company or any
Subsidiary and, to the Company's Knowledge, the other parties (and their
successors) thereto in accordance with their respective terms.

      3.18 Insurance. Schedule 3.18 sets forth a true, complete and correct list
of all insurance policies carried by the Company including the risks insured
against, coverage limits and deductible amounts. There are no outstanding claims
under any of such insurance policies. The Company has not received any insurance
loss runs or workers compensation claims during the past three policy years. The
Company has made available to Parent copies of all insurance policies listed on
Schedule 3.18. Such insurance policies evidence all of the insurance that the
Company or any Subsidiary is required to carry pursuant to all of its contracts
and other agreements and pursuant to all applicable Laws. In the opinion of the
Company's management, the Company and its Subsidiaries have insurance against
the risks involved in the Company's and its Subsidiaries' businesses which is
customary for companies such as the Company and its Subsidiaries. All of such
insurance policies are currently in full force and effect, shall remain in full
force and effect at least until the Closing Date and there is no existing
default or event which, with the giving of notice or lapse of time or both,
could constitute a default thereunder.

                                       17
<PAGE>

      3.19 Compensation; Employment Agreements; Organized Labor Matters. The
Company has provided to Parent true, complete and correct copies of all of the
Company's and its Subsidiaries' employment, consulting or other compensation
agreements except those, if any, which will be terminated on or before Closing
without any further obligation to the Company or its Subsidiaries. Since the
Balance Sheet Date, except as specifically set forth in the Company Public
Reports and for the termination agreement with the Company's CEO and President
(as to which they only received or are entitled to receive shares of Company
Common Stock as part of the Adjustment Issuance and no other compensation other
than reimbursement of proper business expenses incurred in the normal course of
business or other compensation paid in full prior to Closing consisting only of
regular salary, vacation and sick pay amounts consistent with past practices
which amounts were earned and related to actual time worked through the date of
termination), there have been no increases in the compensation payable or any
special bonuses granted to any officer, director, employee, consultant or agent
of the Company.

      Neither the Company nor any Subsidiary is bound by or subject to any
arrangement with any labor union. No employees of the Company or any Subsidiary
are represented by any labor union or covered by any collective bargaining
agreement and no campaign to establish such representation is in progress. There
is no pending or, to the Knowledge of the Company, threatened, labor dispute
involving the Company or any Subsidiary and any group of its employees nor has
the Company or any Subsidiary experienced any labor interruptions over the past
three years. No labor grievance or claim has been made or filed against the
Company or any Subsidiary that is unresolved. The Company believes its and its
Subsidiaries' relationship with their respective employees to be good. All
employees of the Company and its Subsidiaries are legally able to work in the
United States.

      3.20 Employee Plans.

            (a) Neither the Company nor any ERISA Affiliate has at any time
sponsored, maintained, contributed to or been required to make contributions to
any employee benefit, compensation or incentive plan, program, agreement or
arrangement, whether written or oral, for the benefit of any current or former
employee or director of the Company or any ERISA Affiliate, including without
limitation any employment, bonus, deferred compensation, incentive compensation,
stock purchase, stock option, stock appreciation right or other stock-based
incentive, severance, change-in-control, termination pay, hospitalization or
other medical, disability, life or other insurance, supplemental unemployment
benefits, profit sharing, pension, or retirement plan, program, agreement or
arrangement, and including any plan to which more than one employer is required
to make contributions. Neither the Company nor any ERISA Affiliate has made any
promise or agreement or is otherwise under any obligation to establish any such
plan, program, agreement or arrangement in the future. For purposes of this
Agreement, "ERISA Affiliate" means any trade or business, whether or not
incorporated that together with the Company would be deemed a "single employer"
within the meaning of section 4001(b)(1) of the Employee Retirement Income
Security Act of 1974, as amended ("ERISA").

                                       18
<PAGE>

            (b) No Liability under Title IV of ERISA has been incurred by the
Company or any ERISA Affiliate since the effective date of ERISA that has not
been satisfied in full, and no condition exists that presents a risk to the
Company or any ERISA Affiliate of incurring any Liability under such Title.

            (c) None of the Company, the shareholders of the Company nor any
ERISA Affiliate has taken or failed to take any action in connection with which
the Company or any ERISA Affiliate could be subject to any material Liability
for either a civil penalty assessed pursuant to Section 409 or 502(i) of ERISA
or a tax imposed pursuant to Section 4975(a) or (b), 4976 or 4980b of the Code.

            (d) No lien has been imposed under Section 412(n) of the Code or
Section 302(f) of ERISA on the assets of the Company, or any ERISA Affiliate,
and no event or circumstance has occurred that is reasonably likely to result in
the imposition of any such lien on any such assets.

            (e) No amounts payable under any contract, agreement or arrangement
with respect to which the Company may have any Liability to make any current or
future payments could fail to be deductible for federal income tax purposes by
virtue of Section 162(m) or Section 280G of the Code.

            (f) The consummation of the transactions contemplated by this
Agreement will not, either alone or in combination with any other event, (x)
entitle any current or former employee, officer or director of the Company or
any ERISA Affiliate to severance pay, unemployment compensation or any other
similar termination payment, or (y) accelerate the time of payment or vesting,
or increase the amount of or otherwise enhance any benefit due any such
employee, officer or director.

      3.21 Conformity with Law; Litigation. Except for violations which, singly
and in the aggregate, have not had and which would not reasonably be expected to
have, individually or in the aggregate, a Material Adverse Effect on the
Company, the Company and its Subsidiaries are not in violation of any Laws
applicable to either of them or any of their respective properties, assets,
operations and businesses or any regulation or order of any court or federal,
state, local, foreign or other governmental department, commission, board,
bureau, agency or instrumentality ("Governmental Authority") having jurisdiction
over the Company or its assets, properties or businesses. There are no claims,
actions, suits or proceedings, pending or, to the Knowledge of the Company,
threatened against or affecting, the Company, any Subsidiary or their respective
assets, properties or businesses, at law or in equity, or before or by any
Governmental Authority having jurisdiction over the Company, any Subsidiary or
their respective assets, properties or businesses and no notice of any claim,
action, suit or proceeding, whether pending or threatened, has been received by
the Company, and, to the Company's Knowledge, there is no valid basis for any
such claim, action, suit or proceeding. The Company and its Subsidiaries have
conducted and are now conducting their business in compliance with the
requirements, standards, criteria and conditions set forth in applicable Laws
except for violations which, singly and in the aggregate, have not had, and
would not reasonably be expected to have, a Material Adverse Effect on the
Company.

                                       19
<PAGE>

      3.22 Taxes.

            (a) The Company has timely filed, or will timely file, all Tax
Returns required to be filed by or with respect to it or its Subsidiaries on or
prior to the Closing Date. The Company is not now, and has never been, a member
of a combined, consolidated or unitary group for all periods ending on or prior
to the Closing Date, and has paid, or will pay with respect to Tax Returns not
filed as of the date hereof, all Taxes shown on such Tax Returns. All such Tax
Returns were true, complete and correct when they were filed or will be true,
correct and complete when they are filed on or before the Closing Date, and do
not and will not include a disclosure statement under Code Section 6222 or
similar provision under foreign, state or local Tax Law. The Company has timely
paid or made provision for payment of, whether asserted or unasserted,
contingent or otherwise, all Taxes that may have or may become due for all
periods ending on or before the Closing Date, whether or not disclosed on a Tax
Return. The Company has delivered or made available to Parent or its legal or
accounting representatives true, complete and correct copies of all Tax Returns
that the Company has filed for the past three years.

            (b) The Company has not been delinquent in the payment of any Taxes.
There are no pending, or, to the Knowledge of the Company, threatened, claims,
audits, judicial proceedings, assessments or deficiencies with respect to Taxes
of the Company or any Subsidiary. Neither the Company nor any Subsidiary is
liable for any Taxes in any jurisdiction in which it currently does not pay Tax
or file Tax Returns. There is no pending or, to the Knowledge of the Company,
threatened, claim by any Tax authority in any jurisdiction in which the Company
currently does not pay Tax or file Tax Returns that the Company or any
Subsidiary is required to pay material Taxes or file material Tax Returns. No
adjustments have been proposed and are still pending with respect to the Tax
Returns filed by the Company for any open taxable years. Schedule 3.22(b)
contains a complete and accurate list of all completed Tax actions,
examinations, audits, investigations or proceedings, including a reasonably
detailed description of the nature and outcome. The Company has not given or
been requested to give waivers or extensions (or is or would be subject to a
waiver or extension given by any other Person) of any statute of limitations
relating to the payment of Taxes by the Company or any Subsidiary or for which
either may be liable.

            (c) There are no Encumbrances on the assets, properties, income or
operations of the Company or any Subsidiary with respect to any Tax, except for
Permitted Encumbrances.

            (d) There is no Tax sharing agreement, Tax allocation agreement, Tax
indemnity or assumption obligation or similar written or unwritten agreement,
arrangement, understanding or practice with respect to Taxes (including any
advance pricing agreement, closing agreement or other agreement relating to
Taxes with any Tax authority) to which the Company is a party, subject,
obligated or bound in any manner. Neither the Company nor any Subsidiary is
liable for any Taxes pursuant to Treasury Regulation Section 1.1502-6 (or
similar foreign, state or local Tax Law). Neither the Company nor any Subsidiary
is liable, including, without limitation, liability for any Taxes of any other
Person, by contract, by Law or otherwise.

                                       20
<PAGE>

            (e) The net operating losses ("NOL") of the Company are not, as of
the date hereof, subject to Section 382 or 269 of the Code, Regulation Section
1.1502-21T(c), or any similar provision or regulation otherwise limiting the use
of the NOLs of the Company (whether federal, state, local or foreign). The
Company shall not make an election to reattribute the Company's losses to
Company's consolidated group.

            (f) No property of the Company or any Subsidiary (i) is subject to a
Tax benefit transfer lease subject to the provisions of former Section 168(f)(8)
of the Internal Revenue Code of 1954, (ii) is "tax-exempt use property" within
the meaning of Section 168(h) of the Code, or (iii) secures any debt the
interest on which is exempt from tax under Section 103 of the Code.

            (g) Neither the Company nor any Subsidiary is subject to withholding
under Section 1445 of the Code and the Regulations promulgated thereunder, and,
at the Closing Date, the Company shall deliver to Parent a certificate or
certificates to that effect (a "FIRPTA Certificate"). The Company is not a
United States real property holding corporation within the meaning of Section
897(c)(2) of the Code.

            (h) The Company and each Subsidiary (i) has complied with all
applicable legal requirements relating to information reporting and other
requirements with respect to payments made to third parties and the withholding
of any payment of withheld Taxes (including, without limitation, withholding of
Taxes pursuant to Sections 1441 and 1442 of the Code or similar provisions under
any foreign Laws, and Federal Insurance Contribution Act ("FICA") and Federal
Unemployment Tax Act ("FUTA")) and timely paid over to the proper authorities
all amounts required to be so withheld and paid over for all periods in the
manner required by Law, (ii) has timely withheld from employee wages and other
payments and paid over to the proper authorities all amounts required to be so
withheld and paid over for all periods pursuant to all applicable legal
requirements, and (iii) has duly collected and remitted any sales, value-added
and similar Taxes required to be collected and remitted, except for any items
described in (i), (ii) or (iii) that are not yet due to be paid or remitted in
which case such amount has been accrued or reserved for on the Company Balance
Sheet as of the Company Balance Sheet Date or has been accrued since such date
in the ordinary course of business.

            (i) Neither the Company nor any of the Company's Affiliates has been
or is required to make any adjustments under Section 481(a) or Section 263A of
the Code or any comparable provision of any Law, and no Tax authority has
proposed such changes.

            (j) The Company and each Subsidiary is a "United States Person," as
defined in Section 7701(a)(30) of the Code. Neither the Company nor any
Subsidiary has participated or cooperated in any international boycott.

            (k) Except as set forth on Schedule 3.22, the Company does not have
in effect any tax election for U.S. federal income tax purposes under Section
108, 168, 338, 441, 471, 1017, 1033, 1502 or 4977 of the Code, or any similar
election under any Law that could materially adversely affect the Company's Tax
Liability after the Closing Date.

                                       21
<PAGE>

            (l) The charges, accruals, and reserves with respect to Taxes on the
books of the Company are adequate and are at least equal to the Company's
Liability for Taxes accrued through the respective dates of such books. No
consent to the application of Section 341(f)(2) of the Code, has been filed with
respect to any property or assets held, acquired, or to be acquired by the
Company or any Subsidiary. Neither the Company nor any Subsidiary has
participated in any transactions described in Section 367 of the Code.

            (m) Neither the Company nor its Subsidiaries has taken any action
not in accordance with past practice that would have the effect of deferring any
Tax liability of the Company or any Subsidiary from any taxable period ending on
or before the Closing Date to any taxable period ending after the Closing Date.

            (n) The Company, to the Knowledge of the Company's management, has
never been a member of a consolidated group or filed a consolidated U.S. federal
income Tax return other than with its current Subsidiaries.

            (o) The Company is not, and to the knowledge of the Company's
management has never been, a "partner," for U.S. federal income Tax purposes
with any Person.

            (p) All transactions between the Company and any Affiliate of the
Company have complied with Section 482 of the Code, or any similar provision
under state, local or foreign Tax law.

            (q) The Company will not be required to include in a taxable period
ending after the Closing Date taxable income attributable to income that
economically accrued in a taxable period ending on or before the Closing Date as
a result of the installment method of accounting, the completed contract method
of accounting, the percentage of completion method of accounting or any other
method of accounting.

            (r) As used in this Agreement, "Tax" or "Taxes" means (i) any and
all taxes (whether federal, state, local or foreign) including, without
limitation, net or gross income, gross receipts, net proceeds, profits,
property, sales, use, capital stock, net worth, occupation, value added, ad
valorem, transfer, franchise, recapture, excise, windfall, withholding, payroll,
social security, workers' compensation, unemployment compensation or employment
taxes, tariffs, imposts, duties, levies, fees or governmental charges of any
nature whatsoever, whether disputed or not, together with any interest,
penalties or additions to tax imposed with respect to any of the foregoing, and
(ii) any obligations under any agreements or arrangements with respect to any
tax or taxes described in clause (i) above. As used in this Agreement, "Tax
Return" means any return, declaration, report, claim for refund, information
return, or statement, estimated return or statement or other document (including
any related or supporting estimates, elections, schedules, statements or
information) filed or required to be filed in connection with the determination,
assessment or collection of any Tax or the administration of any Laws,
regulations or administrative requirements relating to any Tax.

                                       22
<PAGE>

      3.23 No Violations; No Conflict; No Consents Required, Etc. The Company is
not in violation of any Company Charter Document. The Company and its
Subsidiaries are not nor, to the Knowledge of the Company, is any other party
thereto, in default under any agreement, contract, commitment or other document
that is referred to in the Company Public Reports (collectively, the "Company
Filed Documents") in any manner that has had, or which would reasonably be
expected to result in, individually or in the aggregate, a Material Adverse
Effect on the Company. The execution and delivery of this Agreement, the
performance of the obligations hereunder and the consummation of the
transactions contemplated hereby do not and will not conflict with, or result in
a default under or a breach or violation of, (a) any Law to which the Company
Parent, the Company or any Subsidiary thereof or their respective assets,
properties or businesses are subject or bound, (b) any judgment, order or decree
of any Governmental Authority which is applicable to the Company Parent, the
Company or any Subsidiary thereof or their respective assets, properties or
businesses, or (c) the Company Charter Documents or any securities issued by the
Company, except, with respect to clauses (a) and (b) for any of the same that
has not had and would not reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect on the Company. The execution and delivery
of this Agreement, the performance of the obligations hereunder and the
consummation of the transactions contemplated hereby do not and will not
conflict with, or result in a default under or a breach or violation of, or
adversely affect the rights and benefits afforded to the Company Parent, the
Company or any Subsidiary thereof under, or give any party with rights
thereunder the right to terminate, modify, accelerate or otherwise materially
adversely change the existing rights or obligations of the Company Parent, the
Company or any Subsidiary thereof with respect to, any Company Contracts except
for any of the same that has not had, or which would not reasonably be expected
to have, individually or in the aggregate, a Material Adverse Effect on the
Company. Except as aforesaid, or as specifically contemplated by this Agreement,
no authorization, approval or consent of, and no registration or filing with,
any Governmental Authority is required in connection with the execution,
delivery or performance of this Agreement or the transactions contemplated
hereby by the Company Parent or the Company. None of the Company Filed Documents
prohibits or restricts the Company, its Subsidiaries or any officer, director,
employee, agent or shareholder thereof from freely providing services or
products to any customer or potential customer of the Company, its Subsidiaries,
Parent or Newco except (i) as disclosed in Schedule 3.23, (ii) except with
respect to non-disclosure agreements entered into by the Company in the ordinary
course of its business which may contain prohibitions or restrictions only on
the disclosure, retention, or use of the other Person to such agreement's
confidential or proprietary information or which may contain non-solicitation
provisions, and (iii) any such prohibitions or restrictions under the license
agreements of the Company identified on Schedule 3.15 hereto.

      3.24 Absence of Changes. Since December 31, 2004, other than as disclosed
in the Company Public Reports filed prior to the date hereof, and except for any
Adjustment Issuance or Closing Issuance, termination of the Company's CEO and
the Company's President (as to which they only received or are entitled to
receive shares of Company Common Stock as part of the Adjustment Issuances and
no other compensation other than reimbursement of proper business expenses
incurred in the normal course of business or other compensation paid in full
prior to Closing consisting only of regular salary, vacation and sick pay
amounts consistent with past practices which amounts were earned and related to
actual time worked through the date of termination), and any termination of any
license agreement of the Company or any termination of assignment by Company
Parent or any of its Subsidiaries to Company of Intellectual Property Rights in
contemplation of the transactions contemplated hereby (each as set forth on
Schedule 3.24), there has not been:

                                       23
<PAGE>

            (a) any material adverse change in the business, operations,
properties, assets, condition (financial or otherwise), Liabilities, or income
of the Company and its Subsidiaries, taken as a whole;

            (b) any increase in the aggregate amount of the Company's or any
Subsidiary's indebtedness, including, without limitation, guarantees, other than
in the ordinary course of business or incurred in connection with the
negotiation and consummation of this Agreement;

            (c) any material damage, destruction or casualty loss (whether or
not covered by insurance) affecting the properties, assets or business of the
Company or any Subsidiary;

            (d) any declaration, set aside or payment of any dividend or
distribution of assets or any direct or indirect redemption, purchase or other
acquisition of any of the capital stock of the Company;

            (e) any increase in the compensation, bonus, employee or fringe
benefits, sales commissions or fee arrangement payable or to become payable by
the Company or any Subsidiary to any of its officers, directors, shareholders,
employees, consultants or agents;

            (f) any sale or transfer, or any agreement to sell or transfer, any
business, assets, property or rights of the Company or any Subsidiary to any
Person other than this Agreement or inventory in the ordinary course of business
consistent with past practice;

            (g) any cancellation, or agreement to cancel, any indebtedness or
other obligation owing to the Company or any Subsidiary, including without
limitation any indebtedness or obligation of any Shareholders or any Affiliate
thereof, other than pursuant to this Agreement;

            (h) any plan, agreement, contract, commitment or understanding or
arrangement granting any preferential rights to purchase or acquire any interest
in any of the capital stock, business, assets, property or rights of the Company
or any Subsidiary or requiring consent of any party to the transfer and
assignment of any such capital stock, business, assets, property or rights,
other than pursuant to this Agreement;

            (i) any purchase or acquisition of, or any agreement, plan or
arrangement to purchase or acquire, any assets, property or rights outside of
the ordinary course of the Company's or any Subsidiary's business, or any
expenditure made or commitment incurred to make any expenditure of US$10,000 or
more other than in the ordinary course of the Company's or any Subsidiary's
business;

            (j) any waiver of any material rights or claims of the Company or
any Subsidiary, or, except in the ordinary course of business consistent with
past practice, any amendment or termination of any Company Filed Document or
other right of the Company or any Subsidiary;

                                       24
<PAGE>

            (k) any Encumbrance incurred upon any business, assets or property
of the Company or any Subsidiary, other than Permitted Encumbrances or any
Encumbrance in favor of Company Parent which Encumbrance will be extinguished on
or before Closing;

            (l) the occurrence of any of the prohibited activities by or with
respect to the Company set forth in Sections 5.2, 5.3 or 5.4 hereof;

            (m) any change in any of the accounting principles followed by the
Company or the methods of applying such principles; or

            (n) any agreement or understanding to take any of the actions
referred to above.

      3.25 Deposit Accounts; Powers of Attorney. The Company has delivered or
made available to Parent a true, complete and correct list (set forth on
Schedule 3.25) as of the date of this Agreement of:

            (a) the name of each financial institution in which the Company or
any Subsidiary has accounts or safe deposit boxes;

            (b) the names in which the accounts or boxes are held;

            (c) the type of account and account number; and

            (d) the name of each person authorized to draw thereon or have
access thereto.

No Person holds a general or special power of attorney from the Company or any
Subsidiary.

      3.26 Relations with Governments. Except for political contributions made
in compliance with applicable Laws, neither the Company nor any Affiliate of the
Company acting on behalf of the Company or any Subsidiary has given or offered
anything of value to any governmental official, political party or candidate for
government office, and none of such persons has taken any action which would
cause the Company to be in violation of the Foreign Corrupt Practices Act of
1977, as amended, or any Law of similar effect.

      3.27 No Interests In Other Businesses. To the Knowledge of the Company, no
shareholder and no director, officer or employee of the Company, has any
ownership or similar interest in any business (other than the Company) that is
engaged in the Business. The foregoing representation shall not be construed to
apply to a passive investment of not more than Five percent (5%) of any class of
securities of any publicly traded entity which is engaged in the Business. The
foregoing representations also shall not be construed to apply to any natural
person performing services for any business engaged in the Business if both of
the following conditions are met: (i) such other business is also engaged in
other lines of business and (ii) the natural person's services are restricted to
such other lines of business.

                                       25
<PAGE>

      3.28 Transactions With Affiliates.

            (a) To the Knowledge of the Company, other than as disclosed in the
Company Public Reports and other than with respect to Company Parent (which
transactions are set forth on Schedule 3.28) and with respect to Mr. Paul
Hopper's prior employment relationship with Parent, no shareholder and no
director, officer or employee of the Company, or any member of his or her
immediate family or any other of its, his or her Affiliates, owns or has a 5% or
more ownership interest in any Person that is or was during the last three years
a party to, or in any property or asset which is or was during the last three
years the subject of, any contract, agreement or understanding, business
arrangement or relationship with the Company or any Subsidiary.

            (b) Sections 78.411 through 78.444 ("Combinations with Interested
Stockholders") of the Nevada Revised Statutes do not prohibit the transactions
by Company contemplated by this Agreement, and the transactions contemplated by
this Agreement shall not restrict in any way, or trigger any restriction on, the
Company, Parent, Newco or any Affiliate of the foregoing from undertaking any
"combination" (as defined in such statutes) in the future; provided that the
Company makes no representation as to the future impact of the independent fact
that Parent, Newco or any Affiliate of the foregoing owns a material piece of
the Company.

      3.29 Condition and Sufficiency of Assets. Other than the Company
Intellectual Property, as to which no representation is made pursuant to the
first sentence of this Section, and the real property of the Company, as to
which no representation is made in the first sentence of this Section, the
Company and its Subsidiaries have good and marketable title or leasehold title
or a valid and continuing license to, or right to use all of the tangible
personal property used by the Company or its Subsidiaries in their respective
businesses. The foregoing tangible personal property, together with the Company
Intellectual Property and all of the real property used by the Company or its
Subsidiaries in their respective businesses, represents all of the tangible
personal property, Intellectual Property and real property used by the Company
or its Subsidiaries in their respective businesses as they are currently
operated. Other than the Company Intellectual Property, as to which no
representation is made pursuant to the third sentence of this Section, and the
real property of the Company, as to which no representation is made in the third
sentence of this Section, such tangible personal property is in good operating
condition (ordinary wear and tear excepted) and is free from defect or damage
and from Encumbrances other than Permitted Encumbrances.

      3.30 Takeover Statutes. The Company has, or prior to the Closing shall
have, taken all actions necessary or advisable so that neither the restrictions
set forth in Sections 78.378 through Section 78.3793 ("Acquisition of
Controlling Interest") of the Nevada Revised Statutes nor any restrictive
provision of any other "fair price," "moratorium," "control share acquisition,"
"interested shareholder" or other similar anti-takeover statute or regulation
under Nevada law or restrictive provision of any applicable anti-takeover
provision in the Company Charter Documents will be, applicable to the Company,
Parent, Newco, any Affiliates of the foregoing, any shares of Company Stock
(including, without limitation, the Parent Affiliate Company Stock), or any of
the transactions contemplated by this Agreement.

                                       26
<PAGE>

      3.31 Dissenter's and Appraisal Rights. No Person currently has, and at
Closing no Person shall have, any dissenter's rights, appraisal rights or
similar rights by operation of Law or otherwise with respect to Company Stock.

      3.32 Disclosure. The Company has delivered or made available to Parent and
Newco true, complete and correct copies of each agreement, contract, commitment
or other document that is referred to in the schedules to this Agreement or that
has been requested by Parent or Newco or their representatives. This Agreement
and the schedules hereto do not and as of the Closing Date will not contain any
untrue statement of a material fact or omit to state any material fact required
to be stated therein or necessary in order to make the statements herein and
therein not misleading. If, prior to Closing, the Company or any of its
Affiliates becomes aware of any fact or circumstance that would change a
representation or warranty of the Company in this Agreement or any
representation made by or on behalf of the Company, then the Company or such
Shareholder shall immediately give notice of such fact or circumstance to
Parent.

4. REPRESENTATIONS OF PARENT AND NEWCO

      Except as set forth on a Schedule attached hereto prior to the execution
and delivery of this Agreement corresponding to the section of this Agreement to
which any representations and warranties specifically relate, Parent hereby
represents and warrants to the Company Parent and the Company that:

      4.1 Due Organization. Parent is, and Newco will be (to the extent formed)
at Closing, corporations duly organized, validly existing and in good standing
under the laws of Australia and the United Kingdom, respectively, and Parent
has, and Newco will have (to the extent formed) at Closing, the requisite power
and authority to carry on its business as it is now being conducted and as
currently proposed to be conducted (giving effect to the transactions
contemplated by this Agreement). Parent is, and Newco will be (to the extent
formed) at Closing, duly qualified to do business and are in good standing in
each jurisdiction in which the nature of its business or the ownership or
leasing of its properties makes such qualification necessary, except where the
failure to be so authorized or qualified would not have, individually or in the
aggregate, a Material Adverse Effect on Parent and its Subsidiaries taken as a
whole. Prior to the Closing, Newco will not have engaged in any activities other
than in connection with or as contemplated by this Agreement.

      4.2 Corporate Power; Authorization; Enforceable Obligation. Parent has,
and at its execution of this Agreement Newco will have (to the extent formed),
the full legal right, power and authority to execute and deliver this Agreement,
to perform its obligations hereunder, and to consummate the transactions
contemplated hereby. The execution, delivery and performance of this Agreement
and the consummation of the transactions contemplated hereby have been duly and
validly authorized by the unanimous approval of the Board of Directors of
Parent, and at Closing shall have been duly and validly authorized by the
unanimous approval of the Board of Directors of Newco (to the extent formed)
and, other than approval of the shareholders of Parent ("Parent Shareholder
Approval"), no other corporate action on the part of Parent or Newco will be
necessary to authorize this Agreement or the other agreements, documents,
certificates and instruments required to be delivered hereby or the performance
of the transactions contemplated hereby. This Agreement and the other
agreements, documents, certificates and instruments required to be delivered by
Parent and Newco in accordance with the provisions hereof (the "Parent
Documents") will be duly executed and delivered by Parent and Newco by duly
authorized officers and this Agreement constitutes, and the Parent Documents
when executed and delivered will constitute, the legal, valid and binding
obligations of Parent and Newco, enforceable against Parent and Newco (to the
extent formed) in accordance with their respective terms.

                                       27
<PAGE>

      4.3 Ownership of Gemini Stock. Parent, Newco or a Parent Affiliate is the
record and beneficial owner of 50% of the Gemini Stock and will, immediately
prior to the Closing, be the record and beneficial owner of such Gemini Stock,
free and clear of any Encumbrances other than any Encumbrances arising through
the agreements for the establishment of Gemini and between the shareholders
therein.

      4.4 Available Funds. Parent or Newco has, as of the date of this
Agreement, and will, immediately prior to the Closing, have the funds necessary
to enable it to pay in full in cash at the Closing the cash payment pursuant to
Section 2.

      4.5 No Violations; No Conflict; No Consents Required, Etc. Neither Parent
is, nor will Newco be (to the extent formed), in violation of its charter or
bylaws, each as amended. The execution and delivery of this Agreement, the
performance of the obligations hereunder and the consummation of the
transactions contemplated hereby do not conflict with, result in a default under
or a breach or violation of, adversely affect the rights and benefits afforded
to Parent or Newco or give any party with rights thereunder the right to
terminate, modify, accelerate or otherwise change the existing rights or
obligations of Parent or Newco thereunder by (a) any Law to which Parent or
Newco or their respective assets, properties or businesses are subject or bound,
(b) any judgment, order or decree of any Governmental Authority which is
applicable to Parent or Newco or the assets, properties or businesses of Parent
or Newco, (c) the charter or bylaws of either Parent or Newco or any securities
issued by Parent or Newco, or (d) any material contracts, or other agreement,
contract, commitment, arrangement or understanding, oral or written, to which
Parent or Newco is a party, by which Parent or Newco or any shareholder of
Parent or Newco may have rights or by which any of the properties or assets of
Parent or Newco may be bound or affected, except with respect to clauses (a),
(b) and (d), for any of the same that has not had or will not have, individually
or in the aggregate, a Material Adverse Effect on Parent or Newco. Except as
aforesaid, no authorization, approval or consent of, and no registration or
filing with, any Governmental Authority is required in connection with the
execution, delivery or performance of this Agreement or the transactions
contemplated hereby by Parent or Newco.

      4.6 Compound Intellectual Property. To the extent the Compound is
transferred to the Company, at Closing, Newco or another Parent Affiliate that
becomes a party to this Agreement will own or have licensed (under valid and
continuing licenses) all Intellectual Property Rights that may be necessary for
the Use of the Compound, as the Compound is currently proposed to be Used
("Compound Intellectual Property"), free of all Encumbrances (except, in respect
of licenses, for the Encumbrances pursuant to the licenses themselves) and a
true, complete and correct list of such Compound Intellectual Property will, if
applicable, be set forth in Schedule 4.6. The Compound Intellectual Property and
the use thereof does not and will not infringe or otherwise violate the
copyrights, domain name rights, trademark rights, patent rights, trade secrets,
confidentiality rights or any other rights (including, without limitation,
Intellectual Property Rights) of any Person in any country. To Parent's
Knowledge, there is and has been no unauthorized Use, disclosure, infringement
or misappropriation of any Compound Intellectual Property by any Person,
including, without limitation, any employee, former employee, independent
contractor or former independent contractor of Parent. Parent has taken
appropriate steps to protect and preserve the confidentiality of all Compound
Intellectual Property.

                                       28
<PAGE>

5. COVENANTS PRIOR TO CLOSING

      5.1 Access and Cooperation; Due Diligence.

            (a) The Company will afford to the officers, directors, employees,
consultants, representatives, advisors and agents of Parent and Newco reasonable
access to all of the Company's and its Subsidiaries' sites, properties, books
and records, subject to the Confidentiality Agreement, during the Company's
customary business hours upon reasonable notice and without undue disruption of
the Company's business and will deliver or make available to Parent and Newco
such financial and operating data and other information and documents as to the
business, operations, properties, assets, condition (financial or otherwise),
results of operations and prospects of the Company as Parent or Newco may from
time to time reasonably request. The Company will cooperate with Parent and
Newco and their officers, directors, employees, consultants, representatives,
advisors and agents in the preparation of any documents or other materials which
may be required in connection with any documents or materials required by this
Agreement. If Parent determines that it is not satisfied with the Schedules to
this Agreement or the information and documents received by Parent, Parent may
terminate this Agreement pursuant to Section 9 provided that written notice of
such termination by Parent is received by the Company Parent and/or the Company
not more than seven (7) Business Days after the execution and delivery of this
Agreement by the parties hereto. Parent shall have no right to terminate this
Agreement because it is dissatisfied with the aforesaid Schedules or such
information and documents after the conclusion of such 7-Business Day period.

            (b) Parent and Newco will deliver or make available to the Company
such information and documents as to the subject matter of Parent's
representations and warranties and the Compound, if any, as the Company may from
time to time reasonably request. Parent and Newco will cooperate with the
Company and its officers, directors, employees, consultants, representatives,
advisors and agents in the preparation of any documents or other materials which
may be required in connection with any documents or materials required by this
Agreement. If Company Parent determines that it is not satisfied with the
information and documents received by Company Parent with respect to the
Parent's representations and warranties set forth in Sections 4.1 through and
including 4.5, Company Parent may terminate this Agreement pursuant to Section 9
provided that written notice of such termination by Company Parent is received
by the Parent not more than seven (7) Business Days after the execution and
delivery of this Agreement by the parties hereto. Company Parent shall have no
right to terminate this Agreement because it is dissatisfied with such
information and documents after the conclusion of such 7-Business Day period.
Notwithstanding the foregoing, if the information or documents with respect to
the Compound are not to Company Parent's reasonable satisfaction and written
notice of such determination by the Company Parent is received by Parent not
more than seven (7) Business Days after the execution and delivery of this
Agreement by the parties hereto, at Closing, Parent shall, pursuant to Section
2(c), deliver to the Company US$100,000 instead of the Compound.

                                       29
<PAGE>

            (c) Parent, Newco, the Company Parent and the Company will treat all
information obtained in connection with the negotiation and performance of this
Agreement and the due diligence investigations conducted with respect to the
Company and the Compound as confidential in accordance with the Confidentiality
Agreement, dated as of December 13, 2005, by and between the Company and Parent
(the "Confidentiality Agreement"). No information or knowledge obtained in any
investigation pursuant to this Section or otherwise shall affect or be deemed to
modify any representation or warranty contained in this Agreement or the
conditions to the obligations of the parties to consummate the transactions
contemplated hereby.

      5.2 Conduct of Business Pending Closing.

            (a) From the date hereof through and including the earlier of (x)
the Closing Date and (y) the date this Agreement is terminated in accordance
with Article 9 hereof, and except for any Adjustment Issuance or Closing
Issuance, termination of the Company's CEO and the Company's President (as to
which they only received or are entitled to receive shares of Company Common
Stock as part of the Adjustment Issuances and no other consideration or
compensation other than reimbursement of proper business expenses incurred in
the normal course of business or other consideration paid in full prior to
Closing consisting only of regular salary, vacation and sick pay amounts
consistent with past practices which amounts were earned and related to actual
time worked through the date of termination), and any termination of any license
agreement of the Company or any termination of assignment by Company Parent or
any of its Subsidiaries to Company of Intellectual Property Rights in
contemplation of the transactions contemplated hereby (each as set forth on
Schedule 3.24), the Company and its Subsidiaries will, and the Company Parent
will take all reasonable actions to cause the Company and the Company's
Subsidiaries to do the following:

                  (i) carry on its business in the same manner as it has prior
to the date hereof and not introduce any material new method of management,
operation or accounting;

                  (ii) maintain its properties and facilities, including those
held under leases, in good working order and condition, ordinary wear and tear
excepted;

                  (iii) perform in all material respects all of its obligations
under agreements relating to or affecting its assets, properties, business or
other rights;

                  (iv) keep in full force and effect present insurance policies
or other comparable insurance coverage;

                  (v) use its best efforts to maintain and preserve its
corporate existence and maintain its relationships with suppliers, customers and
others having business relations with the Company;

                                       30
<PAGE>

                  (vi) use its best efforts to maintain compliance with all
Licenses and Laws of Governmental Authority applicable to it or its businesses,
properties or assets; and

                  (vii) maintain present debt and lease instruments and not
enter into new or amended debt or lease instruments without the knowledge and
written consent of Parent.

            (b) From the date hereof through and including the earlier of (x)
the Closing Date and (y) the date this Agreement is terminated in accordance
with Article 9 hereof, neither the Company, the Company Parent nor Parent will
take or omit to take any reasonable action which will cause Gemini to fail to do
any of the following, without the prior written consent of the other parties
hereto, which shall not be unreasonably withheld:

                  (i) carry on its business in the same manner as it has prior
to the date hereof and not introduce any material new method of management,
operation or accounting;

                  (ii) maintain its properties and facilities, including those
held under leases, in good working order and condition, ordinary wear and tear
excepted;

                  (iii) perform in all material respects all of its obligations
under agreements relating to or affecting its assets, properties, business or
other rights;

                  (iv) keep in full force and effect present insurance policies
or other comparable insurance coverage;

                  (v) use its best efforts to maintain and preserve its
corporate existence and maintain its relationships with suppliers, customers and
others having business relations with the Company;

                  (vi) use its best efforts to maintain compliance with all
Licenses and Laws of Governmental Authority applicable to it or its businesses,
properties or assets; and

                  (vii) maintain present debt and lease instruments and not
enter into new or amended debt or lease instruments without the knowledge and
written consent of Parent.

      5.3 Prohibited Activities.

            (a) From the date hereof through and including the earlier of (x)
the Closing Date and (y) the date this Agreement is terminated in accordance
with Article 9 hereof, except for any Adjustment Issuance or Closing Issuance,
termination of the Company's CEO and the Company's President (as to which they
only received or are entitled to receive shares of Company Common Stock as part
of the Adjustment Issuances and no other consideration or compensation other
than reimbursement of proper business expenses incurred in the normal course of
business or other consideration paid in full prior to Closing consisting only of
regular salary, vacation and sick pay amounts consistent with past practices
which amounts were earned and related to actual time worked through the date of
termination), and any termination of any license agreement of the Company or any
termination of assignment by Company Parent or any of its Subsidiaries to
Company of Intellectual Property Rights in contemplation of the transactions
contemplated hereby (each as set forth on Schedule 3.24), the Company and its
Subsidiaries will not, and the Company Parent will cause the Company and the
Company's Subsidiaries to not, without the prior written consent of Parent:

                                       31
<PAGE>

                  (i) make any change in the Company Charter Documents other
than pursuant to Section 2(e) of this Agreement;

                  (ii) issue any options, warrants, calls, rights,
subscriptions, claims of any character, agreements, obligations, convertible or
exchangeable securities, or other commitments (contingent or otherwise) of any
kind relating to its securities;

                  (iii) declare or pay any dividend, or declare or make any
distribution in respect of its capital stock, or any direct or indirect
redemption or purchase, or other acquisition for value, of any shares of its
capital stock;

                  (iv) make any changes in the compensation payable or to become
payable to any of its officers, directors, shareholders, employees, Affiliates,
consultants or agents or to any other persons providing services;

                  (v) make any loans to any of its officers, directors,
shareholders, employees, Affiliates, consultants, representatives, advisors or
agents or made any change in its existing borrowing or lending arrangements for
or on behalf of any such Persons, whether pursuant to any employee benefit plan
or otherwise;

                  (vi) grant, issue, accelerate, pay, accrue or agree to pay or
make any accrual or arrangement for payment of salary, bonus or other payments
or benefits pursuant to, or adopt or amend, any new or existing plan
contemplated by Section 3.20(a);

                  (vii) enter into any contract or commitment or incur or agree
to incur any new Liability or make any capital expenditures, except (a) in the
ordinary course of business consistent with past practice and (b) for any other
Liability, in each case of (a) and (b) which shall be fully and completely
discharged on or before Closing and any Liabilities to Parent, Newco or any
other Parent Affiliate arising by virtue of this Agreement;

                  (viii) sell, assign, lease or otherwise transfer or dispose of
any assets, property or rights except in the ordinary course of business
consistent with past practices;

                  (ix) purchase or acquire, or agree to purchase or acquire, any
property, rights or assets except in the ordinary course of business consistent
with past practices except as contemplated hereby;

                  (x) merge or consolidate or agree to merge or consolidate with
or into any other Person;

                  (xi) cancel or agree to cancel any indebtedness or other
obligation owing to the Company, or waive any rights or claims of the Company,
provided that the Company may negotiate and adjust bills and accounts in the
course of good faith disputes with customers in a manner consistent with past
practice;

                                       32
<PAGE>

                  (xii) amend in a manner adverse to the Company or terminate
any agreement, License or other right of the Company without Parent's written
consent, which consent shall not be unreasonably withheld or delayed;

                  (xiii) enter into any other transaction outside the ordinary
course of the Company's business other than this Agreement and the
implementation hereof; or

                  (xiv) agree to do any of the foregoing.

            (b) From the date hereof through and including the earlier of (x)
the Closing Date and (y) the date this Agreement is terminated in accordance
with Article 9 hereof, neither the Company, Company Parent nor Parent will take
or omit to take any reasonable action which will cause Gemini to do any of the
following, without the prior written consent of the other parties hereto, which
shall not be unreasonably withheld:

                  (i) make any change in Gemini's charter documents;

                  (ii) issue any options, warrants, calls, rights,
subscriptions, claims of any character, agreements, obligations, convertible or
exchangeable securities, or other commitments (contingent or otherwise) of any
kind relating to its securities;

                  (iii) declare or pay any dividend, or declare or make any
distribution in respect of its capital stock, or any direct or indirect
redemption or purchase, or other acquisition for value, of any shares of its
capital stock;

                  (iv) make any changes in the compensation payable or to become
payable to any of its officers, directors, shareholders, employees, Affiliates,
consultants or agents or to any other persons providing services;

                  (v) make any loans to any of its officers, directors,
shareholders, employees, Affiliates, consultants, representatives, advisors or
agents or made any change in its existing borrowing or lending arrangements for
or on behalf of any such Persons, whether pursuant to any employee benefit plan
or otherwise;

                  (vi) grant, issue, accelerate, pay, accrue or agree to pay or
make any accrual or arrangement for payment of salary, bonus or other payments
or benefits pursuant to, or adopt or amend, any new or existing plan
contemplated by Section 3.20(a);

                  (vii) enter into any contract or commitment or incur or agree
to incur any Liability or make any capital expenditures, except in the ordinary
course of business consistent with past practice and, in any case, not
individually or in the aggregate in excess of US$50,000;

                  (viii) sell, assign, lease or otherwise transfer or dispose of
any assets, property or rights except in the ordinary course of business
consistent with past practices;

                                       33
<PAGE>

                  (ix) purchase or acquire, or agree to purchase or acquire, any
property, rights or assets except in the ordinary course of business consistent
with past practices except as contemplated hereby;

                  (x) merge or consolidate or agree to merge or consolidate with
or into any other Person;

                  (xi) cancel or agree to cancel any indebtedness or other
obligation owing to Gemini, or waive any rights or claims of Gemini, provided
that Gemini may negotiate and adjust bills and accounts in the course of good
faith disputes with customers in a manner consistent with past practice;

                  (xii) amend in a manner adverse to Gemini or terminate any
agreement, License or other right of Gemini;

                  (xiii) enter into any other transaction outside the ordinary
course of Gemini's business; or

                  (xiv) agree to do any of the foregoing.

            (c) Prior to the earlier of the Closing Date or the date this
Agreement is terminated in accordance with Article 9 hereof, neither Parent,
Company Parent nor Company will take any action to sell, transfer or otherwise
assign any of their respective interests in Gemini, or to encumber the same, or
to agree to do any of the foregoing, without the prior written consent of the
other parties hereto.

                                       34
<PAGE>

      5.4 No Solicitation. The Company Parent and the Company will not, and will
not authorize or permit any of their Subsidiaries or any of their or their
Subsidiaries' respective employees, consultants, agents, officers, directors,
shareholders, trustees, representatives or Affiliates (including any investment
banker, attorney or accountant retained by their or any of their Subsidiaries)
to, directly or indirectly solicit, initiate, encourage, propose, seek or
facilitate (including by way of furnishing information) any inquiries or the
making or implementation of proposals or offers from any Person for or that
could reasonably be expected to lead to a merger, reorganization, share
exchange, consolidation, business combination, recapitalization, liquidation,
dissolution or similar transaction involving the Company or any of its
Subsidiaries, or any purchase or sale of the consolidated assets (including
without limitation stock of Subsidiaries) of the Company and its Subsidiaries,
taken as a whole, having an aggregate value equal to 50% or more of the market
capitalization of the Company, or any purchase or sale of, or tender or exchange
offer for, 50% or more of the equity securities of the Company (any such
proposal or offer (other than a proposal or offer made by a Parent Affiliate)
being hereinafter referred to as an "Acquisition Proposal"). The Company Parent
and the Company each further agrees that neither it nor any of their respective
Subsidiaries shall, nor will they authorize or permit any of their or their
respective Subsidiaries' employees, consultants, agents, officers, directors,
shareholders, trustees, representatives and Affiliates to, directly or
indirectly, have any discussion with or provide any non-public information or
data to any Person relating to the Company or any of its Subsidiaries in
connection with a potential Acquisition Proposal, or engage in any negotiations
concerning a potential Acquisition Proposal, or facilitate any effort or attempt
to make, negotiate or implement a potential Acquisition Proposal or accept an
Acquisition Proposal. Notwithstanding anything in this Agreement to the
contrary, the Company or the Company Board shall be permitted to (A) to the
extent applicable, comply with Rule 14d-9 and Rule 14e-2 promulgated under the
Exchange Act with regard to an Acquisition Proposal, (B) effect a Change in the
Company Recommendation in accordance with Section 5.7, or (C) engage in any
discussions or negotiations with, or provide any information to, any Person in
response to an unsolicited bona fide written Acquisition Proposal by any such
Person, if and only to the extent that, in any such case as is referred to in
clause (C), (i) the Company Shareholders Meeting shall not have occurred and the
Company Written Consents shall not have been received by the Company, (ii) the
Company Board concludes in good faith (I) after consultation with its
independent financial advisor, that there is a reasonable likelihood that such
Acquisition Proposal would result in a Superior Proposal, and (II) after
consultation with its outside legal counsel, that failure to take such action
would be reasonably expected to result in a breach of the directors' fiduciary
duties under applicable law, (iii) prior to providing any information or data to
any Person in connection with an Acquisition Proposal by any such Person, the
Company Board receives from such Person an executed confidentiality agreement
customary for a transaction of this type on terms that are substantially similar
to and no less favorable to the Company than those set forth in the
Confidentiality Agreement, and (iv) prior to providing any information or data
to any Person or entering into discussions or negotiations with any Person, the
Company notifies Parent promptly (but in no event later than 24 hours after
receipt) of such inquiries, proposals or offers received by, any such
information requested from, or any such discussions or negotiations sought to be
initiated or continued with, any of its representatives indicating, in
connection with such notice, the name of such Person and the material terms and
conditions of any inquiries, proposals or offers. The Company agrees that it
will keep Parent informed of the status and terms of any such proposals or
offers and the status and terms of any such discussions or negotiations. The
Company agrees that it will, and will cause its officers, directors and
representatives to, immediately cease and cause to be terminated any activities,
discussions or negotiations existing as of the date of this Agreement with any
parties conducted heretofore with respect to any Acquisition Proposal. The
Company agrees that it will use its best efforts to promptly inform its
directors, officers, key employees, agents and representatives of the
obligations undertaken in this Section 5.4. Nothing in this Section 5.4 shall
(x) permit Parent, the Company Parent or the Company to terminate this Agreement
(except as specifically provided in Section 9 hereof) or (y) affect any other
obligation of Parent, the Company Parent or the Company under this Agreement.

      5.5 Notification of Certain Matters. Without limiting the foregoing, prior
to the Closing, the Company shall give prompt notice to Parent and Newco of (i)
the occurrence or non-occurrence of any event which would cause or would be
likely to cause any representation or warranty of the Company contained herein
to be untrue or inaccurate as of the Closing and (ii) any failure of the Company
to comply with or satisfy any covenant, condition or agreement to be complied
with or satisfied by such Person hereunder prior to or at the Closing. Prior to
the Closing, Parent and Newco shall give prompt notice to the Company of (i) the
occurrence or non-occurrence of any event which would cause or would be likely
to cause any representation or warranty of Parent or Newco contained herein to
be untrue or inaccurate as of the Closing and (ii) any failure of Parent or
Newco to comply with or satisfy any covenant, condition or agreement to be
complied with or satisfied by it hereunder prior to or at the Closing. The
delivery of any notice pursuant to this Section 5.5 shall not be deemed to (i)
modify the representations or warranties hereunder of the party delivering such
notice or (ii) modify the conditions set forth in Sections 6 and 7 hereof.

                                       35
<PAGE>

      5.6 Proxy or Information Statement.

            (a) As promptly as reasonably practicable after the execution of
this Agreement, the Company shall prepare and file with the SEC a proxy
statement or information statement, as applicable, relating to the meeting of
the shareholders of the Company or the Company Written Consents, as applicable,
with respect to this Agreement and the transactions contemplated hereby
(together with any amendments thereof or supplements thereto, the "Proxy
Statement"). The Company shall prepare and file with the SEC any other filings
required to be made by the Company ("Other Filings"), as the case may be, as and
when required or requested by the SEC. The Company will use all reasonable best
efforts to respond to any comments made by the SEC with respect to the Proxy
Statement and any Other Filings as promptly as practicable. Each of Parent and
Newco shall furnish all information concerning it as the Company may reasonably
request in connection with such actions and the preparation of the Proxy
Statement and any Other Filings. At the earliest practicable time following the
later of (i) receipt and resolution of SEC comments thereon, or (ii) the
expiration of the 10-day waiting period provided in Rule 14a-6(a) promulgated
under the Exchange Act, the Company shall file definitive proxy or information
statement materials with the SEC and cause the Proxy Statement to be mailed to
its shareholders. Prior to filing the preliminary proxy or information statement
materials, definitive proxy or information statement materials or any other
filing with the SEC or any other Governmental Authority, the Company shall
provide Parent and Newco with reasonable opportunity to review and comment on
each such filing in advance. The Company will advise Parent and Newco promptly
after it receives notice thereof, of any request by the SEC for amendment of the
Proxy Statement or any Other Filings or comments thereon and responses thereto
or requests by the SEC for additional information.

            (b) Parent and Newco agree that the information supplied by Parent
and Newco for inclusion in the Proxy Statement shall not, at (i) the time the
Proxy Statement (including with respect to any amendments thereof or supplements
thereto) is first mailed to the Company's shareholders and (ii) the time of the
meeting of the shareholders of the Company contemplated by clause (a) ("Company
Shareholders Meeting"), contain any untrue statement of a material fact or omit
to state any material fact required to be stated therein or necessary in order
to make the statements contained therein not misleading. If, at any time prior
to the Closing, any event or circumstance relating to Parent, Newco or any
Parent or Newco Subsidiary, or their respective officers or directors, should be
discovered by Parent or Newco that should be set forth in an amendment or a
supplement to the Proxy Statement or any Other Filing, Parent or Newco shall
promptly inform the Company in writing.

            (c) The Company agrees that the Proxy Statement (other than
information supplied by Parent or Newco for inclusion in the Proxy Statement)
shall not, at (i) the time the Proxy Statement (including with respect to any
amendments thereof or supplements thereto) is first mailed to the Company's
shareholders and (ii) the time of the Company Shareholders Meeting, contain any
untrue statement of a material fact or omit to state any material fact required
to be stated therein or necessary in order to make the statements contained
therein not misleading. If, at any time prior to the Closing, any event or
circumstance relating to the Company, the Company Parent or any Company Parent
Subsidiary, or their respective officers or directors, should be discovered by
the Company or Company Parent that should be set forth in an amendment or a
supplement to the Proxy Statement or any Other Filing, the Company or Company
Parent shall promptly inform Parent and Newco.

                                       36
<PAGE>

            (d) The Company Parent shall cause the Company to comply with its
duties under this Section 5.6 and Section 5.7.

      5.7 Company and Parent Shareholders Meeting; Board Recommendation.

            (a) The Company shall call and hold the Company Shareholders Meeting
as promptly as reasonably practicable (and in no event later than 45 days after
mailing of the Proxy Statement) for the purpose of obtaining the approval of the
shareholders of the Company unless the Company Written Consents have been
received. In connection with any Company Shareholders Meeting, the Company will
(i) subject to applicable Laws, use its reasonable best efforts (including
postponing or adjourning the Company Shareholders Meeting to obtain a quorum or
to solicit additional proxies) to obtain the approval of the shareholders of the
Company and (ii) otherwise comply with all applicable Law pertaining to the
Company Shareholders Meeting.

            (b) Subject to the proviso below and to the extent there is a
Company Shareholders Meeting, the Board of Directors of the Company (the
"Company Board") shall unanimously recommend ("Company Recommendation" that the
Company's shareholders vote in favor of the adoption of this Agreement, (ii) the
Proxy Statement shall include a statement to the effect that the Company Board
has unanimously recommended that the Company's shareholders vote in favor of the
adoption of this Agreement at the Company Shareholders Meeting, and (iii)
neither the Company Board nor any committee thereof shall withhold, withdraw,
amend or modify, or propose or resolve to withhold, withdraw, amend or modify in
a manner adverse to Parent or Newco, such recommendation of the Company Board
(collectively, a "Change in the Company Recommendation"); provided the foregoing
shall not prohibit accurate disclosure (and such disclosure shall not be deemed
to be a Change in the Company Recommendation) of factual information regarding
the business, financial condition or results of operations of the Company or the
fact that an Acquisition Proposal has been made, the identity of the party
making such proposal or the material terms of such proposal (provided that the
Company Board does not withdraw, modify or qualify in any manner adverse to
Parent its recommendation) in the Proxy Statement or Other Filings, to the
extent such factual information is required to be disclosed under applicable
Law; and, provided further, that the Company Board may make a Change in the
Company Recommendation prior to the earlier to occur of the Company Shareholders
Meeting and the receipt by the Company of the Company Written Consents if the
Company Board determines in good faith, after consultation with outside counsel,
that the failure to effect such Change in the Company Recommendation would be
reasonably expected to result in a breach of the fiduciary duties of the
Company's directors under applicable Law, but following receipt of any
Acquisition Proposal, the Company Board may make a Change in the Company
Recommendation pursuant to this Section 5.7(b) by reason of such Acquisition
Proposal only if such Acquisition Proposal is a Superior Proposal; and, provided
further, that the Board of Directors of the Company may make a Change in the
Company Recommendation prior to the earlier to occur of the Company Shareholders
Meeting and the receipt by the Company of the Company Written Consents, if a
Material Adverse Effect has occurred with respect to Gemini, or on the Parent or
Parent Affiliates' ownership of its Gemini Stock, or the ability of Parent or
the applicable Parent Affiliate to transfer the Gemini Stock pursuant to this
Agreement. Notwithstanding any Change in the Company Recommendation, this
Agreement shall be submitted to the shareholders of the Company at the Company
Shareholders Meeting for the purpose of adopting the Agreement and approving the
transactions contemplated hereby; provided that this Agreement shall not be
required to be submitted to the shareholders of the Company at the Company
Shareholders Meeting if this Agreement has been terminated pursuant to Section 9
hereof or if the Company shall have already received the Company Written
Consents.

                                       37
<PAGE>

            (c) Parent shall duly take all lawful and commercially reasonable
action to call, give notice of, convene and hold a meeting of its shareholders
on a date as soon as reasonably practicable after the execution and delivery of
the Agreement consistent with the Parent's restructuring plan (the "Parent
Shareholders Meeting") for the purpose of obtaining the Parent Shareholder
Approval and shall take all lawful and commercially reasonable action to solicit
the approval of this Agreement and the Board of Directors of Parent shall
recommend approval of this Agreement by the shareholders of Parent (the "Parent
Recommendation"), and shall not change in any manner adverse to the Company such
recommendation (collectively, a "Change in the Parent Recommendation"); provided
the foregoing shall not prohibit accurate disclosure (and such disclosure shall
not be deemed to be a Change in the Parent Recommendation) of factual
information regarding the business, financial condition or operations of Parent
or the Company (provided that the Board of Directors of Parent does not
withdraw, modify or qualify in any manner adverse to the Company its
recommendation), to the extent such factual information, is required to be
disclosed under applicable law; provided further, that the Board of Directors of
Parent may make a Change in the Parent Recommendation prior to Parent
Shareholders Meeting if a Material Adverse Effect has occurred with respect to
the Company; and provided further, that the Board of Directors of Parent may
make a Change in the Parent Recommendation prior to the Parent Shareholders
Meeting if the Board of Directors of Parent determines in good faith, after
consultation with outside counsel, that the failure to effect such Change in the
Parent Recommendation would be reasonably expected to result in a breach of the
fiduciary duties of Parent's directors under applicable Law, but a Change in the
Parent Recommendation may only be made in respect of an alternate offer or
proposal for the acquisition, directly or indirectly, of the Gemini Stock by a
Person other than the Company if such offer or proposal is a Superior Proposal;
and, provided further, that the Parent Board may make a Change in the Parent
Recommendation prior to the Parent Shareholders Meeting, if a Material Adverse
Effect has occurred with respect to the Company or Gemini, the Company's
ownership of its Gemini Stock or the ability of the Company to transfer the
Parent Affiliate Company Stock pursuant to this Agreement. Notwithstanding any
Change in the Parent Recommendation, a proposal to approve this Agreement shall
be submitted to the shareholders of Parent at the Parent Shareholders Meeting
for the purpose of obtaining the Parent Shareholder Approval; provided that this
Agreement shall not be required to be submitted to the shareholders of Parent at
the Parent Shareholders Meeting if this Agreement has been terminated pursuant
to Section 9 hereof.

                                       38
<PAGE>

            (d) For purposes of this Agreement, a Change in the Company
Recommendation or Change in the Parent Recommendation, as applicable, shall be
deemed to include, without limitation, a recommendation by the Company Board of
Directors or the Parent Board of Directors, as applicable, of a third party
Acquisition Proposal with respect to the Company.

      5.8 Newco(a) . Promptly after the execution and delivery of this Agreement
by Parent, the Company and Company Parent, Parent may organize Newco as
contemplated by the recitals of this Agreement and if so organized shall cause
Newco to become a party to this Agreement by executing a counterpart signature
page to this Agreement and delivering the same to the Company and Company
Parent.

      5.9 Further Assurances(a) . The parties hereto agree to execute and
deliver, or cause to be executed and delivered, such further instruments and
documents and take such other action as may be reasonably necessary or
convenient to carry out the transactions contemplated hereby.

      5.10 Joint Venture Agreement. The parties agree that at all times prior to
the Closing or earlier termination of this Agreement, (a) Parent will fund all
amounts required to be funded pursuant to the Joint Venture Agreement, dated as
of October 5, 2004, by and among Parent and the Company Parent (the "Joint
Venture Agreement"), whether or not Company Parent is required to fund the same
pursuant to the Joint Venture Agreement, until the earlier of Closing or the
termination of this Agreement, and (b) the Company Parent's payment obligations
under the Joint Venture Agreement will be suspended and undertaken by Parent
until the earlier of (i) Closing (at which time the Company Parent shall be
released from any and all obligations under the Joint Venture Agreement, and the
Parent shall be released from all of its obligations arising under the Joint
Venture Agreement after the date of Closing) and (ii) the termination of this
Agreement (at which time each of the Company Parent and the Parent will have its
respective obligations under the Joint Venture Agreement as exist immediately
prior to the date hereof). After the Closing, the parties agree that the Joint
Venture Agreement shall terminate and neither Parent nor Company Parent shall
have any further obligations to make payments or otherwise thereunder for any
obligations incurred from that date forward and Company.

6. CONDITIONS PRECEDENT TO OBLIGATIONS OF THE COMPANY

      The obligations of the Company Parent and the Company with respect to
actions to be taken on the Closing Date are subject to the satisfaction or
written waiver by the Company on or prior to the Closing Date of the following
conditions:

      6.1 Representations and Warranties; Performance of Obligations. All
representations and warranties of Parent and Newco (to the extent formed)
contained in Section 4 shall be true, complete and correct as of the Closing
Date as though such representations and warranties had been made as of that
time, except for such representations which speak as of a specific date, which
shall continue to be true, complete and correct as of the applicable date; all
of the terms, covenants and conditions of this Agreement to be complied with and
performed by Parent and Newco at or before the Closing shall have been duly
complied with and performed; and a certificate to the foregoing effect dated the
Closing Date and signed by the chief executive officer of Parent and Newco (to
the extent formed) shall have been delivered to the Company.

                                       39
<PAGE>

      6.2 No Litigation. No action or proceeding before a court or any other
Governmental Authority shall have been instituted and be continuing or
threatened to restrain or prohibit the transactions contemplated hereby.

      6.3 Consents and Approvals. All necessary consents and approvals of and
filings with any Governmental Authority relating to the consummation of the
transactions contemplated herein shall have been obtained and made. The approval
of the shareholders of the Company to the transactions contemplated herein and
in the documents contemplated hereby shall have been obtained.

      6.4 No Material Adverse Effect. No event or circumstance shall have
occurred which has had or is reasonably likely to have, individually or in the
aggregate, a Material Adverse Effect on Gemini, on the Parent Affiliates'
ownership of its Gemini Stock proposed to be transferred pursuant to this
Agreement or the ability of the applicable Parent Affiliate to transfer the
Gemini Stock pursuant to this Agreement; and the Company shall have received on
the Closing Date a certificate signed by Parent and Newco and, to the extent
applicable, such other Parent Affiliate, dated the Closing Date to such effect.

      6.5 Secretary's Certificate. The Company shall have received a
certificate, dated the Closing Date and signed by the Secretary or an Assistant
Secretary of each of Parent and Newco, certifying the truth, completeness and
correctness of attached copies of the Parent and Newco Charter Documents and
resolutions of the boards of directors of Parent and Newco and of the
shareholders of Parent and Newco approving Parent's and Newco's execution and
delivery of this Agreement, the consummation of the transactions contemplated
hereby, and the performance of their respective obligations hereunder.

      6.6 Contribution by Parent Affiliate. Parent and Newco shall have
performed their obligations pursuant to Section 2(a), (b), and (c) to the
reasonable satisfaction of Company and Company Parent.

      6.7 Resolution of Disputes. Company Parent and the Company shall have
received releases of any and all liabilities of each of Company Parent, the
Company and their respective officers, directors, employees, representatives,
consultants and agents, with respect to Gemini, which releases shall be
reasonably satisfactory in form and in substance to each of the Company Parent,
the Company and the Parent.

      6.8 Parent Shareholder Agreement. Dr. Richard Opara shall have executed
and delivered to the Company a Shareholder Agreement in substantially the form
of Annex I attached hereto at the time of signing and such agreement shall be in
full force and effect through and including the Closing with no breach thereof
by Dr. Opara.

      6.9 Noncompetition, Nondisclosure and Release Agreements. Parent, Newco,
and the officers, directors and employees of the Company upon consummation of
Closing shall have executed and delivered to Company and Company Parent
Noncompetition, Nondisclosure and Release Agreements in form and substance
reasonably satisfactory to Company Parent and to Parent with respect to the
Business.

                                       40
<PAGE>

      6.10 Company Charter Documents; Voting Agreement. The Company Charter
Documents shall be amended and restated in a form and in substance mutually
agreeable to Company Parent and Parent to reflect, among other things, (i) that
the Nevada Revised Statutes "Combinations with Interested Stockholder,"
"Acquisition of Controlling Interests" and similar provisions do not apply to
the transaction contemplated by this Agreement or to Parent, Newco or their
respective Affiliates and (ii) restrictions on actions by Company post-Closing
without the approval of Company Parent so long as Company Parent owns 20% or
more of the capital stock of the Company on a Fully Diluted Basis, and such
other matters, if any, as may be mutually agreed by Company Parent and Parent,
unless as to item (ii), the Company Parent and Parent agree to address such
matters in a voting agreement.

7. CONDITIONS PRECEDENT TO OBLIGATIONS OF PARENT, NEWCO AND GEMINI

      The obligations of Parent and Newco with respect to actions to be taken on
the Closing Date are subject to the satisfaction or written waiver by Parent and
Newco on or prior to the Closing Date of all of the following conditions:

      7.1 Representations and Warranties; Performance of Obligations. All the
representations and warranties of the Company Parent and the Company contained
in this Agreement shall be true, complete and correct as of the Closing Date
with the same effect as though such representations and warranties had been made
on and as of that time except for such representations which speak as of a
specific date, which shall continue to be true, complete and correct as of the
applicable date; all of the terms, covenants and conditions of this Agreement to
be complied with or performed by the Company Parent or the Company at or before
the Closing shall have been duly performed or complied with; and certificates to
the foregoing effect dated the Closing Date and signed by the chief executive
officer of the Company Parent and the Company shall have been delivered to
Parent and Newco.

      7.2 No Litigation. No action or proceeding before a court or any other
Governmental Authority or body shall have been instituted and be continuing or
threatened to restrain or prohibit the transactions contemplated hereby.

      7.3 Consents and Approvals. All necessary consents and approvals of and
filings with any Governmental Authority relating to the consummation of the
transactions contemplated herein shall have been obtained and made, and all
necessary consents and approvals of third parties shall have been obtained. The
approval of the shareholders of Parent to the restructuring of Parent, including
the transactions contemplated herein and in the documents contemplated hereby,
shall have been obtained.

      7.4 Good Standing Certificates. The Company shall have delivered to Parent
a certificate, dated as of a date no earlier than five days prior to the Closing
Date and a bring down within two business days of the Closing Date, if
available, duly issued by the appropriate Governmental Authority in the State of
Nevada showing the Company is in good standing and authorized to do business and
that all state franchise taxes for the Company for all periods prior to the
Closing have been paid.

                                       41
<PAGE>

      7.5 No Material Adverse Effect. No event or circumstance shall have
occurred which has had or is reasonably likely to have, individually or in the
aggregate, a Material Adverse Effect on the Company, on Gemini or on the
Company's ownership of its Gemini Stock, or the ability of the Company to
transfer the Parent Affiliate Company Stock pursuant to this Agreement; and
Parent shall have received on the Closing Date a certificate signed by the
Company dated the Closing Date to such effect.

      7.6 Secretary's Certificate. Parent shall have received a certificate,
dated the Closing Date and signed by the Secretary or an Assistant Secretary of
the Company, certifying the truth, completeness and correctness of attached
copies of the Company's Certificate of Incorporation, Bylaws and resolutions of
the Company Board and of the shareholders of the Company approving the Company's
execution and delivery of this Agreement, the consummation of the transactions
contemplated hereby, and the performance of their respective obligations
hereunder.

      7.7 Noncompetition, Nondisclosure and Release Agreements. The Company
Parent and the officers, directors and employees of the Company as of the date
hereof shall have executed and delivered to Parent Noncompetition, Nondisclosure
and Release Agreements in form and substance reasonably satisfactory to Company
Parent and to Parent with respect to the Business.

      7.8 Resolution of Disputes. Parent and Newco shall have received releases
of any and all liabilities of any of them, and their respective officers,
directors, employees, representatives, consultants and agents, with respect to
Gemini, which releases shall be reasonably satisfactory in form and in substance
to Parent, Newco and the Company Parent.

      7.9 Company Shareholder Agreement. The Company Parent shall have executed
and delivered to Parent a Shareholder Agreement in substantially the form of
Annex II attached hereto at the time of signing and such agreement shall be in
full force and effect through and including the Closing with no breach thereof
by Company Parent.

      7.10 Registration Rights Agreement. The Company shall have executed and
delivered to Parent a Registration Rights Agreement in form and substance
reasonably satisfactory to Parent and the Company Parent.

      7.11 Company Charter Documents. The Company Charter Documents shall be
amended and restated in a form and in substance mutually agreeable to Company
Parent and Parent to reflect, among other things, (i) that the Nevada Revised
Statutes "Combinations with Interested Stockholder," "Acquisition of Controlling
Interests" and similar provisions do not apply to the transaction contemplated
by this Agreement or to Parent, Newco or their respective Affiliates and (ii)
restrictions on actions by Company post-Closing without the approval of Company
Parent so long as Company Parent owns 20% or more of the capital stock of the
Company on a Fully Diluted Basis, and such other matters, if any, as may be
mutually agreed by Company Parent and Parent, unless as to item (ii), the
Company Parent and Parent agree to address such matters in a voting agreement.

      7.12 FIRPTA. The Company shall have delivered to Parent the FIRPTA
Certificate.

                                       42
<PAGE>

      7.13 Filing of Form 10-KSB. The Company shall have filed, in accordance
with the rules and regulations of the Exchange Act, a true, complete and correct
Form 10-KSB for its fiscal year ended December 31, 2005, including therein
audited financial statements and an opinion by Cacciamatta Accountancy
Corporation on such financial statements.

8. INDEMNIFICATION

      8.1 Indemnification.

            (a) Subject to Section 8.4, Company Parent (the "Company
Indemnifying Party") hereby covenants and agrees, to indemnify, defend, protect
and hold harmless Parent, Newco, and, subsequent to the Closing, the Company and
their respective officers, shareholders, employees, directors, Affiliates,
Subsidiaries, agents, successors and assigns (collectively, the "Parent
Indemnitees"), at all times from and after the date of this Agreement until the
Expiration Date (as defined in Section 8.4 hereof) from and against all claims,
damages, actions, suits, proceedings, demands, assessments, adjustments, costs
and expenses (including, without limitation, reasonable attorneys' fees and
expenses) incurred by Parent, Newco, the Company (after the Closing) or any
Parent Indemnitees (collectively, "Loss") as a result of, in connection with or
arising from (i) any inaccuracy in or breach of any representation and warranty
of the Company Parent or the Company set forth in this Agreement or in any
Company Document or on the schedules or (ii) any breach of any term, covenant,
condition or agreement on the part of the Company Parent or the Company under
this Agreement or the Company Documents.

            (b) Subject to Section 8.4, Avantogen and Newco, jointly and
severally (the "Parent Indemnifying Party") hereby covenants and agrees, to
indemnify, defend, protect and hold harmless Company Parent and, prior to the
Closing, the Company and their respective officers, shareholders, employees,
directors, Affiliates, Subsidiaries, agents, successors and assigns
(collectively, the "Company Indemnitees"), at all times from and after the date
of this Agreement until the Expiration Date (as defined in Section 8.4 hereof)
from and against all Losses incurred by the Company Parent, the Company (prior
to the Closing) or any Company Indemnitees as a result of, in connection with or
arising from (i) any inaccuracy in or breach of any representation and warranty
of Parent or Newco set forth in this Agreement or in any Parent Document or on
the schedules or (ii) any breach of any term, covenant, condition or agreement
on the part of Parent or Newco under this Agreement or the Parent Documents.

      8.2 Third Person Claims.

            (a) Promptly after any party hereto who has the right or may have
the right to seek indemnification under this Section 8 (hereinafter the
"Indemnified Party") has received notice of or has knowledge of any claim by a
Person not a party to this Agreement ("Third Person"), or of the commencement of
any action or proceeding by a Third Person, the Indemnified Party shall give
prompt written notice of such claim or the commencement of such action or
proceeding to the Company Indemnifying Party or the Parent Indemnifying Party,
as applicable (the "Indemnifying Parties"); provided, however, that the failure
to provide such prompt notice shall not release the Indemnifying Parties from
any of their obligations under this Article 8 to the extent the Indemnifying
Parties are not prejudiced or harmed by such failure. Such notice shall, to the
extent known, state in reasonable detail the nature and the basis of such claim
and a reasonable estimate of the amount thereof.

                                       43
<PAGE>

            (b) The Indemnifying Parties shall have the right to defend and
settle, at its own expense and by its own counsel, any such matter so long as
the Indemnifying Party pursues the same in good faith and diligently, provided
that the Indemnifying Party shall not settle any proceeding (including the
consent to entry of any judgment (other than a judgment or dismissal on the
merits without costs)) without the written consent of the Indemnified Party,
which consent shall not be unreasonably withheld or delayed.

            (c) If the Indemnifying Parties undertake to defend or settle such
matter, they shall promptly notify the Indemnified Party of their intention to
do so, and the Indemnified Party shall cooperate with the Indemnifying Parties
and their counsel in the defense thereof and in any settlement thereof. Such
cooperation shall include, but shall not be limited to, furnishing the
Indemnifying Parties with any reasonably applicable books, records or
information reasonably requested by the Indemnifying Parties that are in the
Indemnified Party's possession or control and making available all reasonably
applicable personnel and advisors of the Indemnified Party reasonably requested
by the Indemnifying Parties.

            (d) All Indemnified Parties shall be represented by the same
counsel, which shall be counsel selected by the Indemnifying Parties and
reasonably acceptable to the Indemnified Parties, provided that if the
Indemnified Parties believe that counsel to the Indemnifying Parties has or may
have a conflict of interest or a potential conflict of interest that prevents or
could prevent such counsel from properly representing the Indemnified Party, the
Indemnified Party shall have the right to control and assume the defense of such
matter through one firm of counsel and appropriate local counsel of its own
choosing and the Indemnifying Parties will reimburse the Indemnified Party for
the reasonable fees and expenses of such counsel. After the Indemnifying Parties
have notified the Indemnified Party of their intention to undertake to defend or
settle any such asserted Liability, and for so long as the Indemnifying Parties
in good faith diligently pursue such defense, the Indemnifying Parties shall not
be liable for any additional legal expenses incurred by the Indemnified Party in
connection with any defense or settlement of such asserted Liability, except (i)
as set forth in the preceding sentence, (ii) to the extent such participation of
attorneys for the Indemnified Party is requested by the Indemnifying Parties,
(iii) as agreed upon in writing with the Indemnified Party for reasonable fees
and expenses, in which event the Indemnified Party shall be reimbursed by the
Indemnifying Parties. If the Indemnifying Parties do not promptly and timely
undertake to defend such matter to which the Indemnified Party is entitled to
indemnification hereunder, or fails to in good faith diligently pursue such
defense, the Indemnified Party may control and assume such defense through
counsel of its choice, at the cost and expense of the Indemnifying Parties, and
the Indemnified Party may settle such matter, and the Indemnifying Parties shall
reimburse the Indemnified Party for the amount paid in such settlement and any
other Liabilities or expenses (including, without limitation, reasonable legal
fees and expenses of such counsel) incurred by the Indemnified Party in
connection therewith; provided, however, that under no circumstances shall the
Indemnified Party settle any Third Person claim without the written consent of
the Indemnifying Parties, which consent shall not be unreasonably withheld or
delayed. All settlements pursuant to this Section 8 shall effect a complete
release of the Indemnified Party as to such claims or matters, unless the
Indemnified Party otherwise agrees in writing.

                                       44
<PAGE>

            (e) Notwithstanding anything to the contrary in this Section 8, if
at any time, in the reasonable opinion of Parent, Newco or, after the Closing
Date, the Company (notice of which opinion shall be given in writing to the
Indemnifying Party), any Third Person claim seeks prospective relief (other than
monetary damages) which could have a materially adverse effect on any such
Indemnified Party or any Subsidiary or Affiliate thereof, then such Indemnified
Party shall have the right to control and/or assume (as the case may be) the
defense of any such Third Person claim and the amount of any judgment or
settlement and the reasonable costs and expenses of defense (including, without
limitation, legal fees and expenses of counsel, experts, consultants, and
engineers) shall be included as part of the indemnification obligations of the
Indemnifying Parties hereunder; provided, however, that if such prospective
relief is sought from an Indemnifying Party or its Affiliates or Subsidiaries
and an Indemnified Party or its Affiliates or Subsidiaries, the Indemnified
Party and the Indemnifying Party shall work together and jointly control the
defense of such claim. If the Indemnified Party elects to exercise such right,
then the Indemnifying Parties shall have the right to participate in, but not
control, the defense of such Third Person claim at the sole cost and expense of
the Indemnifying Parties provided that the Indemnifying Parties shall only be
obligated to reimburse fees and expenses pursuant hereto for one firm of counsel
(and appropriate local counsel) for such Indemnified Parties.

      8.3 Limitations on Indemnification.

            (a) No Person shall assert any claim for indemnification hereunder
against an Indemnifying Party until such time as the aggregate of all claims
which such Persons may have against such Indemnifying Party shall exceed Two
Hundred Thousand United States Dollars (US$200,000), exclusive of legal fees and
expenses of the Indemnified Party (the "Indemnification Threshold") at which
time an Indemnified Party shall be entitled to seek indemnification for the
entire amount of all such claims; provided, however, that claims for breaches of
the representations and warranties set forth in Sections 3.2 (the last
sentence), 3.4, 3.5, 3.6, 3.10(b) (the third, fourth and sixth sentences), 3.14,
3.20, and 3.22 and Sections 4.2 (the last sentence), 4.3 and 4.6 and fraud or
intentional misrepresentations or breaches shall not be subject to the
Indemnification Threshold limitation set forth in this Section 8.3(a).

            (b) The aggregate Liability of the Indemnifying Parties for
indemnification hereunder shall not exceed Fifteen Million United States Dollars
(US$15,000,000); provided, however, that claims of breaches of the
representations and warranties set forth in Sections 3.2 (the last sentence),
3.4, 3.5, 3.10(b) (the third, fourth and sixth sentences), 3.14, 3.20, 3.22,
3.28(b), 3.30 and 3.31 and Sections 4.2 (the last sentence), 4.3 and 4.6 and
fraud or intentional misrepresentations or breaches shall not be subject to the
limitation set forth in this Section 8.3(b).

      8.4 Survival of Representations and Warranties. The parties agree that
representations and warranties made by the parties in this agreement, or in any
certificate or other instrument delivered pursuant to this Agreement, shall
survive through and including March 31, 2008 (which date is hereinafter called
the "Expiration Date"), except that:

                                       45
<PAGE>

            (a) the representations and warranties contained in Section 3.22
hereof shall survive until 60 days after the applicable statute of limitations
period has run for all tax periods ended prior to the Closing Date, which shall
be deemed to be the Expiration Date for purposes of this clause (a) and claims
arising from a breach of the representations and warranties contained in such
Section 3.21;

            (b) the representations and warranties contained in Section 3.20
hereof shall survive until 60 days after the applicable statute of limitations
period has run on all matters covered by Section 3.20, which shall be deemed to
be the Expiration Date for purposes of this clause (b) and claims arising from a
breach of the representations and warranties contained in such Section 3.20;

            (c) the representations and warranties contained in Section 3.14
hereof shall survive for a period of five years from the Closing Date, which
shall be deemed the Expiration Date for purposes of this clause (c) and claims
arising from a breach of the representations and warranties contained in such
Section 3.14; and

            (d) the representations and warranties contained in Sections 3.2,
3.3, 3.4 and 3.5 and Sections 4.2 and 4.3 hereof shall survive the Closing Date
without time limitation.

9. TERMINATION OF AGREEMENT

      9.1 Termination. This Agreement may be terminated at any time prior to the
Closing Date solely:

            (a) by mutual consent of the Boards of Directors of Parent and the
Company;

            (b) by any party if the transactions contemplated by this Agreement
to take place at or prior to the Closing shall not have been consummated by the
date one hundred twenty (120) days after the date of this Agreement, unless the
failure of such transactions to be consummated is due to the willful failure of
the party (including, in the case of Parent and Newco; either Parent or Newco
and, in the case of the Company Parent and the Company, either the Company
Parent or the Company) seeking to terminate this Agreement to materially perform
any of its obligations under this Agreement to the extent required to be
performed by it prior to or on the Closing Date;

            (c) by the Company or Company Parent if a material breach or default
shall be made by Parent or Newco (or Parent or Newco's Affiliates) in the
observance or in the due and timely performance of any of the covenants or
agreements contained herein, and the curing of such default shall not have been
made before the Closing Date;

            (d) by Parent or Newco if a material breach or default shall be made
by the Company Parent or the Company (or the Company Parent's or the Company's
Affiliates) in the observance or in the due and timely performance of any of the
covenants or agreements contained herein, and the curing of such default shall
not have been made before the Closing Date;

            (e) by Parent or Newco pursuant to Section 5.1(a);

                                       46
<PAGE>

            (f) by Company Parent pursuant to Section 5.1(b);

            (g) by Parent or Newco if (i) the Company Board shall have withdrawn
or changed or modified the Company Recommendation in a manner adverse to Parent
or (ii) the Company materially breaches its obligations under this Agreement by
reason of a failure to call and hold the Company Shareholders Meeting in
accordance with Section 5.7 in the event that the Company Written Consents have
not been received;

            (h) by the Company Parent or Company if (i) the Parent Board shall
have withdrawn or changed or modified the Parent Recommendation in a manner
adverse to the Company Parent or (ii) Parent materially breaches its obligations
under this Agreement by reason of a failure to call and hold the Parent
Shareholders Meeting in accordance with Section 5.7;

            (i) by Parent or Newco, if prior to the Parent Shareholder Approval,
(i) the Board of Directors of Parent authorizes Parent, subject to complying
with the terms of this Agreement, to enter into a binding written agreement
concerning a transaction that constitutes a Superior Proposal to Parent and
Parent notifies the Company in writing that it intends to enter into such an
agreement, attaching the most current version of such agreement (or a
description of all material terms and conditions thereof) to such notice and
(ii) the Company does not make, within five (5) Business Days of receipt of the
Parent's written notification of its intention to enter into a binding agreement
for such Superior Proposal, an offer that the Board of Directors of Parent
determines, in good faith after consultation with a reputable financial advisor,
is at least as favorable to Parent's shareholders as such Superior Proposal, it
being understood that Parent shall not enter into any such binding agreement
during such five (5) Business-Day period;

            (j) by Company Parent or the Company, if prior to the Company
Shareholder Approval or the receipt by the Company of the Company Written
Consents, the (i) Company Board authorizes the Company, subject to complying
with the terms of this Agreement, to enter into a binding written agreement
concerning a transaction that constitutes a Superior Proposal to the Company and
the Company notifies Parent in writing that it intends to enter into such an
agreement, attaching the most current version of such agreement (or a
description of all material terms and conditions thereof) to such notice, (ii)
Parent does not make, and Company Parent does not receive from Parent, within
three (3) Business Days of receipt by Parent of the Company's written
notification of its intention to enter into a binding agreement for such
Superior Proposal, a binding written offer by Parent that the Company Board
determines, in good faith after consultation with a reputable financial advisor,
is at least as favorable to the Company's shareholders as such Superior
Proposal, it being understood that the Company shall not enter into any such
binding agreement during such three (3) Business-Day period; or

            (k) by the Company or Parent, if the Company Shareholders Meeting or
the Parent Shareholders Meeting shall have been held and the Company Shareholder
Approval or the Parent shareholder approval shall not have been obtained at such
meeting (including any adjournment or postponement thereof permitted by this
Agreement) or through the receipt by the Company or Parent of proper written
consents sufficient to provide all necessary approvals for this Agreement and
the transaction contemplated hereby (the "Company Written Consents" or the
"Parent Written Consents," as applicable).

                                       47
<PAGE>

      9.2 Liabilities in Event of Termination(a) . The termination of this
Agreement shall not limit any obligation or Liability of any party based on or
arising from a breach or default by such party with respect to any of its
representations, warranties, covenants or agreements contained in this
Agreement.

10. COVENANTS POST-CLOSING

      10.1 Payment of Taxes. All transfer, documentary, sales, use,
registration, value added and other such Taxes and fees (including any penalties
and interest) incurred in connection with this Agreement (including any real
property transfer tax and any similar Tax) or the transactions contemplated
hereby shall be paid one-half by Company Parent and one-half by Parent or Newco
when due, and the Company will, at the expense of the Company, file all
necessary Tax Returns and other documentation with respect to all such Taxes and
fees, and, if required by applicable legal requirements, Parent will, and will
cause its Affiliates to, join in the execution of any such Tax Returns and other
documentation.

      10.2 Transfer Restrictions. Unless otherwise agreed by the Company after
the Closing, and except for transfers by Parent to a Parent Affiliate or Company
Parent to any Company Parent Affiliate who, in either case, agrees in advance of
such transfer in a written instrument reasonably satisfactory to the other
parties hereto to be subject to this Agreement, none of Parent or Newco, as
applicable, or the Company Parent shall sell, assign, exchange, transfer,
encumber, pledge, distribute, or otherwise dispose of any shares of Parent
Affiliate Company Stock or Company Stock for 12 months from Closing Date. No
person shall serve as a member of the Board of Directors or as an officer of
Company after Closing who does not agree to be bound by this covenant.

      10.3 Registration of Parent Affiliate Company Stock. Promptly after the
Closing, the Company shall register all Parent Affiliate Company Stock pursuant
to the Registration Rights Agreement contemplated in Section 7.

      10.4 Cooperation on Tax Matters. From and after the Closing, the Company,
the Company Parent, Parent and Newco shall cooperate fully, as and to the extent
reasonably requested by the other, in connection with the preparation and filing
of any Tax Return, statement, report or form (including without limitation any
report required pursuant to Section 6043 of the Code and all regulations
promulgated thereunder), any audit, litigation or other proceeding with respect
to Taxes. Such cooperation shall include the retention and (upon the other
party's request) the provision of records and information which are reasonably
relevant to any such audit, litigation or other proceeding and making employees
available on a mutually convenient basis to provide additional information and
explanation of any material provided hereunder. The Company, Company Parent,
Parent and Newco agree to retain all books and records with respect to Tax
matters pertinent to the Company relating to any tax period ending on or prior
to the Closing Date, and to abide by all record retention agreements entered
into with any Tax authority.

                                       48
<PAGE>

11. GENERAL

      11.1 Cooperation. The Company, Parent, the Company, Parent and Newco
shall, subject to the terms and provisions hereof, each deliver or cause to be
delivered to the other on the Closing Date, and at such other times and places
as shall be reasonably agreed to, such additional documents and instruments as
the other may reasonably request for the purpose of carrying out the
transactions contemplated by this Agreement. The Company will cooperate and use
its best efforts to have the officers, directors and employees of the Company
cooperate with Parent and Company Parent, prior to the Closing Date, and Parent
and Newco, on and after the Closing Date, will cause the Company and its
officers, directors and employees to so cooperate, in furnishing information,
evidence, testimony and other assistance in connection with any tax return
filing obligations, actions, proceedings, arrangements or disputes of any nature
with respect to matters pertaining to all periods prior to the Closing Date.

      11.2 Successors and Assigns. This Agreement and the rights of the parties
hereunder may not be assigned (except by operation of law or as expressly stated
hereunder) and shall be binding upon and shall inure to the benefit of the
parties hereto. This Agreement is not intended to create any third party
beneficiaries other than pursuant to the express provisions of Section 8 hereof.

      11.3 Entire Agreement. This Agreement (including the schedules, exhibits
and annexes attached hereto and the documents contemplated hereby and thereby)
sets forth the entire understanding of the parties relating to the subject
matter of this Agreement and cancels and supersedes all agreements, arrangements
and understanding relating thereto made prior to or on the date hereof, written
or oral, between the parties to this Agreement.

      11.4 Counterparts. This Agreement may be executed by the parties hereto in
separate counterparts, each of which when so executed and delivered shall be an
original but all such counterparts together shall constitute one and the same
instrument.

      11.5 Brokers and Agents. Each party represents and warrants that it
employed no broker or agent in connection with this transaction and agrees to
indemnify the other parties hereto against all loss, cost, damages or expense
arising out of claims, actions, suits, proceedings, demands or assessments for
fees or commission of brokers employed or alleged to have been employed by such
indemnifying party.

      11.6 Expenses. Except as expressly provided in Section 10.1, whether or
not the transactions herein contemplated shall be consummated, (a) Parent and/or
Newco shall pay the fees, expenses and disbursements of Parent and/or Newco and
their respective agents, representatives, accountants and counsel incurred in
connection with the subject matter of this Agreement and the transactions
contemplated hereby, and (b) the Company Parent shall pay all fees, expenses and
disbursements of the Company Parent and the Company and their respective agents,
representatives, accountants, counsel and other advisors or professionals
incurred in connection with the subject matter of this Agreement and the
transactions contemplated hereby incurred, as to the Company, through and
including, the Closing.

                                       49
<PAGE>

      11.7 Notices. All notices and other communications under this Agreement
shall be in writing and shall be given by hand delivery, facsimile, or
nationally recognized overnight courier, and shall be deemed to have been duly
given 1) if delivered by hand, on the date of such delivery, 2) if delivered by
facsimile, on the date of such delivery, with receipt of appropriate
confirmation, and 3) if delivered by nationally recognized overnight courier, on
the business day following dispatch to the respective persons named below:

            (a) If to Parent, or Newco, addressed to them at:

                Avantogen Limited
                4660 La Jolla Village Drive
                Suite 420
                San Diego, CA 92122
                Attn: CEO
                Fax: 858-458-6893
                with copies to:
                Kaye Scholer LLP
                1999 Avenue of the Stars, Suite 1700
                Los Angeles, California  90067-6048
                Attention: Barry Lawrence, Esq.
                Fax: (310) 788-1200

            (b) If to the Company or to Company Parent prior to the Closing
Date, addressed to it at:

                Bioaccelerate Holdings, Inc.
                712 Fifth Avenue, 19th Floor
                New York, New York  10019
                Reference: Avantogen Limited/Innovate Oncology, Inc. Transaction

                Fax: (212) 581-1922

Any party may change such party's address for notices by notice duly given
pursuant hereto.

      11.8 Governing Law. This Agreement shall be governed by and construed and
enforced in accordance with the laws of the New York applicable to contracts
entirely negotiated, executed and performed within that State, without giving
effect to the conflict of law principles thereof.

      11.9 Jurisdiction and Venue.

            (a) Each of the parties hereto hereby irrevocably and
unconditionally submits, for itself, herself or himself and its, hers or his
property, to the nonexclusive jurisdiction of any New York state court or U.S.
federal court sitting in New York, New York, and any appellate court therefrom,
in any suit, action or proceeding arising out of or relating to this Agreement
or the transactions contemplated hereunder, and each of the parties hereto
hereby irrevocably and unconditionally agrees that all claims in respect of any
such suit, action or proceeding may be heard and determined in any such New York
state court or U.S. federal court. Each of the parties hereto agrees that a
final judgment in any such suit, action or proceeding shall be conclusive and
may be enforced in other jurisdictions by suit on the judgment or in any other
manner provided by law.

                                       50
<PAGE>

            (b) Each of the parties hereto irrevocably and unconditionally
waives, to the fullest extent it or he may legally and effectively do so, any
objection that it or he may now or hereafter have to the laying of venue of any
suit, action or proceeding arising out of or relating to this Agreement or the
transactions contemplated hereunder in any New York state court or U.S. federal
court sitting in New York, New York. Each of the parties hereto irrevocably
waives, to the fullest extent permitted by law, the defense of an inconvenient
forum to the maintenance of such suit, action or proceeding in any such court.

      11.10 Survival of Representations and Warranties. The representations,
warranties, covenants and agreements of the parties made herein and at the time
of the Closing or in writing delivered pursuant to the provisions of this
Agreement shall survive the consummation of the transactions contemplated hereby
and any examination or investigation on behalf of the parties until the
applicable Expiration Date.

      11.11 Exercise of Rights and Remedies. Except as otherwise provided
herein, no delay of or omission in the exercise of any right, power or remedy
accruing to any party as a result of any breach or default by any other party
under this Agreement shall impair any such right, power or remedy, nor shall it
be construed as a waiver of or acquiescence in any such breach or default, or of
any similar breach or default occurring later; nor shall any waiver of any
single breach or default be deemed a waiver of any other breach or default
occurring before or after that waiver.

      11.12 Time. Time is of the essence with respect to this Agreement.

      11.13 Reformation and Severability. In case any provision of this
Agreement shall be held to be invalid, illegal or unenforceable, it shall, to
the extent possible, be modified in such manner as to be valid, legal and
enforceable but so as to most nearly retain the intent of the parties, and if
such modification is not possible, such provision shall be severed from this
Agreement, and in either case the validity, legality and enforceability of the
remaining provisions of this Agreement and the future application of such
provision shall not in any way be affected or impaired thereby.

      11.14 Remedies Cumulative. No right, remedy or election given by any term
of this Agreement shall be deemed exclusive but each shall be cumulative with
all other rights, remedies and elections available at law or in equity.

      11.15 Captions. The headings of this Agreement are inserted for
convenience only, shall not constitute a part of this Agreement or be used to
construe or interpret any provision hereof.

      11.16 Representation by Counsel. Each party to this Agreement represents
and warrants that such party has been represented by counsel in the negotiation,
drafting and execution of this Agreement. Accordingly, no provision of this
Agreement shall be construed against any party on the grounds that party drafted
the provision or caused it to be drafted.

                                       51
<PAGE>

      11.17 Amendments; Waivers. This Agreement may be amended, modified or
canceled and the terms or covenants hereof may be waived, only by a written
instrument executed by the parties, or in the case of a waiver, by the party
waiving compliance. The failure of any party at any time or times to require
performance of any provision hereof shall in no manner affect the right of such
party at a later time to enforce the same. No waiver by any party of the breach
of any term or covenant contained in this Agreement, whether by conduct or
otherwise, in any one or more instances, shall be deemed to be, or construed as,
a further or continuing waiver of any such breach, or a waiver of the breach of
any other term or covenant contained in this Agreement.

      11.18 Public Announcements. The parties hereto agree that no announcement
relating to the transactions contemplated hereby shall be made by any party
hereto or any of their Affiliates or representatives without the prior written
consent and involvement of each other party, except as may be required by any
applicable Law or Governmental Authority.

                  [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

                                       52
<PAGE>

      IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of
the day and year first above written.

AVANTOGEN LIMITED

      /s/ Dr. Richard Opara
-----------------------------------
By:   Dr. Richard Opara
Its:  Chairman of the Board

                                       53
<PAGE>

BIOACCELERATE HOLDINGS, INC.

/s/ Lee Cole
-----------------------------------
By:  Lee Cole
Its: Chairman of the Board

                                       54
<PAGE>

INNOVATE ONCOLOGY, INC.

      /s/ Paul Hopper
-----------------------------------
By:   Paul Hopper
Its:  Chairman of the Board

                                       55
<PAGE>

                                     ANNEX I

                      Form of Parent Shareholder Agreement

                                       56
<PAGE>

                                    ANNEX II

                      Form of Company Shareholder Agreement

                                       57

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00097-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00097-of-00352.parquet"}]]